| Year |
Citation |
Score |
| 2024 |
Ziontz J, Harrison TM, Chen X, Giorgio J, Adams JN, Wang Z, Jagust W. Behaviorally meaningful functional networks mediate the effect of Alzheimer's pathology on cognition. Cerebral Cortex (New York, N.Y. : 1991). 34. PMID 38602736 DOI: 10.1093/cercor/bhae134 |
0.405 |
|
| 2024 |
Maboudian SA, Willbrand EH, Jagust WJ, Weiner KS. Defining overlooked structures reveals new associations between cortex and cognition in aging and Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 38383497 DOI: 10.1523/JNEUROSCI.1714-23.2024 |
0.37 |
|
| 2024 |
Fonseca CS, Baker SL, Dobyns L, Janabi M, Jagust WJ, Harrison TM. Tau accumulation and atrophy predict amyloid independent cognitive decline in aging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38334195 DOI: 10.1002/alz.13654 |
0.388 |
|
| 2024 |
Landau SM, Lee J, Murphy A, Ward TJ, Harrison TM, Baker SL, DeCarli C, Harvey D, Tosun D, Weiner MW, Koeppe RA, Jagust WJ. Individuals with Alzheimer's disease and low tau burden: Characteristics and implications. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38241084 DOI: 10.1002/alz.13609 |
0.688 |
|
| 2023 |
Giorgio J, Adams JN, Maass A, Jagust WJ, Breakspear M. Amyloid induced hyperexcitability in default mode network drives medial temporal hyperactivity and early tau accumulation. Neuron. PMID 38096815 DOI: 10.1016/j.neuron.2023.11.014 |
0.31 |
|
| 2023 |
Chen X, Toueg TN, Harrison TM, Baker SL, Jagust WJ. Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults. Annals of Neurology. PMID 37789559 DOI: 10.1002/ana.26813 |
0.468 |
|
| 2023 |
Han F, Lee J, Chen X, Ziontz J, Ward T, Landau SM, Baker SL, Harrison TM, Jagust WJ. Global brain activity and its coupling with cerebrospinal fluid flow is related to tau pathology. Biorxiv : the Preprint Server For Biology. PMID 37745434 DOI: 10.1101/2023.09.12.557492 |
0.628 |
|
| 2023 |
Mundada NS, Rojas JC, Vandevrede L, Thijssen EH, Iaccarino L, Okoye OC, Shankar R, Soleimani-Meigooni DN, Lago AL, Miller BL, Teunissen CE, Heuer H, Rosen HJ, Dage JL, Jagust WJ, et al. Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment. Alzheimer's Research & Therapy. 15: 157. PMID 37740209 DOI: 10.1186/s13195-023-01302-w |
0.365 |
|
| 2023 |
Veitch DP, Weiner MW, Miller M, Aisen PS, Ashford MA, Beckett LA, Green RC, Harvey D, Jack CR, Jagust W, Landau SM, Morris JC, Nho KT, Nosheny R, Okonkwo O, et al. The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37698424 DOI: 10.1002/alz.13449 |
0.6 |
|
| 2023 |
Cassady KE, Chen X, Adams JN, Harrison TM, Zhuang K, Maass A, Baker S, Jagust W. Effect of Alzheimer's pathology on task-related brain network reconfiguration in aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 37604690 DOI: 10.1523/JNEUROSCI.0023-23.2023 |
0.353 |
|
| 2023 |
Giorgio J, Tanna A, Malpetti M, White SR, Wang J, Baker S, Landau S, Tanaka T, Chen C, Rowe JB, O'Brien J, Fripp J, Breakspear M, Jagust W, Kourtzi Z. A robust harmonization approach for cognitive data from multiple aging and dementia cohorts. Alzheimer's & Dementia (Amsterdam, Netherlands). 15: e12453. PMID 37502020 DOI: 10.1002/dad2.12453 |
0.605 |
|
| 2023 |
Markova TZ, Ciampa CJ, Parent JH, LaPoint MR, D'Esposito M, Jagust WJ, Berry AS. Poorer aging trajectories are associated with elevated serotonin synthesis capacity. Molecular Psychiatry. PMID 37460847 DOI: 10.1038/s41380-023-02177-x |
0.817 |
|
| 2023 |
Jagust WJ, Teunissen CE, DeCarli C. The complex pathway between amyloid β and cognition: implications for therapy. The Lancet. Neurology. PMID 37454670 DOI: 10.1016/S1474-4422(23)00128-X |
0.523 |
|
| 2023 |
Maboudian SA, Willbrand EH, Jagust WJ, Weiner KS. Defining overlooked structures reveals new associations between cortex and cognition in aging and Alzheimer's disease. Biorxiv : the Preprint Server For Biology. PMID 37425904 DOI: 10.1101/2023.06.29.546558 |
0.384 |
|
| 2023 |
Taylor CM, Furman DJ, Berry AS, White Iii RL, Jagust WJ, D'Esposito M, Jacobs EG. Striatal dopamine synthesis and cognitive flexibility differ between hormonal contraceptive users and nonusers. Cerebral Cortex (New York, N.Y. : 1991). PMID 37160338 DOI: 10.1093/cercor/bhad134 |
0.584 |
|
| 2023 |
Zavecz Z, Shah VD, Murillo OG, Vallat R, Mander BA, Winer JR, Jagust WJ, Walker MP. NREM sleep as a novel protective cognitive reserve factor in the face of Alzheimer's disease pathology. Bmc Medicine. 21: 156. PMID 37138290 DOI: 10.1186/s12916-023-02811-z |
0.828 |
|
| 2023 |
Dobyns L, Zhuang K, Baker SL, Mungas D, Jagust WJ, Harrison TM. An empirical measure of resilience explains individual differences in the effect of tau pathology on memory change in aging. Nature Aging. 3: 229-237. PMID 37118122 DOI: 10.1038/s43587-022-00353-2 |
0.366 |
|
| 2023 |
Nho K, Risacher SL, Apostolova L, Bice PJ, Brosch J, Deardorff R, Faber K, Farlow MR, Foroud T, Gao S, Rosewood T, Kim JP, Nudelman K, Yu M, Aisen P, ... ... Jagust WJ, et al. Novel Alzheimer's disease locus identified by genome-wide association analysis of cerebral tau deposition on PET. Medrxiv : the Preprint Server For Health Sciences. PMID 36993271 DOI: 10.1101/2023.02.27.23286048 |
0.728 |
|
| 2022 |
Harrison TM, Ward TJ, Murphy A, Baker SL, Dominguez PA, Koeppe R, Vemuri P, Lockhart SN, Jung Y, Harvey DJ, Lovato L, Toga AW, Masdeu J, Oh H, Gitelman DR, ... ... Jagust WJ, et al. Optimizing quantification of MK6240 tau PET in unimpaired older adults. Neuroimage. 119761. PMID 36455762 DOI: 10.1016/j.neuroimage.2022.119761 |
0.843 |
|
| 2022 |
Ossenkoppele R, Pichet Binette A, Groot C, Smith R, Strandberg O, Palmqvist S, Stomrud E, Tideman P, Ohlsson T, Jögi J, Johnson K, Sperling R, Dore V, Masters CL, Rowe C, ... ... Jagust WJ, et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nature Medicine. 28: 2381-2387. PMID 36357681 DOI: 10.1038/s41591-022-02049-x |
0.345 |
|
| 2022 |
Weiner MW, Veitch DP, Miller MJ, Aisen PS, Albala B, Beckett LA, Green RC, Harvey D, Jack CR, Jagust W, Landau SM, Morris JC, Nosheny R, Okonkwo OC, Perrin RJ, et al. Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36209495 DOI: 10.1002/alz.12797 |
0.586 |
|
| 2022 |
Parent JH, Ciampa CJ, Harrison TM, Adams JN, Zhuang K, Betts MJ, Maass A, Winer JR, Jagust WJ, Berry AS. Locus coeruleus catecholamines link neuroticism and vulnerability to tau pathology in aging. Neuroimage. 119658. PMID 36191755 DOI: 10.1016/j.neuroimage.2022.119658 |
0.828 |
|
| 2022 |
Zhuang K, Chen X, Cassady KE, Baker SL, Jagust WJ. Metacognition, cortical thickness, and tauopathy in aging. Neurobiology of Aging. 118: 44-54. PMID 35868093 DOI: 10.1016/j.neurobiolaging.2022.06.007 |
0.404 |
|
| 2022 |
Ranasinghe K, Verma P, Cai C, Xie X, Kudo K, Gao X, Lerner H, Mizuiri D, Strom A, Iaccarino L, La Joie R, Miller BL, Gorno-Tempini ML, Rankin KP, Jagust WJ, et al. Altered excitatory and inhibitory neuronal subpopulation parameters are distinctly associated with tau and amyloid in Alzheimer's disease. Elife. 11. PMID 35616532 DOI: 10.7554/eLife.77850 |
0.311 |
|
| 2022 |
Morris JC, Weiner M, Xiong C, Beckett L, Coble D, Saito N, Aisen PS, Allegri R, Benzinger TLS, Berman SB, Cairns NJ, Carrillo MC, Chui HC, Chhatwal JP, Cruchaga C, ... ... Jagust WJ, et al. Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology. Brain : a Journal of Neurology. PMID 35580594 DOI: 10.1093/brain/awac181 |
0.604 |
|
| 2022 |
Apple AC, Lindbergh CA, Landau SM, DeLuca A, Eberling JL, Jagust WJ, Kramer JH, Rugo HS, Heflin LH. Longitudinal Trajectories of Memory Performance in Patients with Early-Stage Breast Cancer. Journal of Oncology. 2022: 5899728. PMID 35469310 DOI: 10.1155/2022/5899728 |
0.53 |
|
| 2022 |
LaPoint MR, Baker SL, Landau SM, Harrison TM, Jagust WJ. Rates of β-amyloid deposition indicate widespread simultaneous accumulation throughout the brain. Neurobiology of Aging. 115: 1-11. PMID 35447369 DOI: 10.1016/j.neurobiolaging.2022.03.005 |
0.651 |
|
| 2022 |
Landau SM, Ward TJ, Murphy A, Iaccarino L, Harrison TM, La Joie R, Baker S, Koeppe RA, Jagust WJ. Quantification of amyloid beta and tau PET without a structural MRI. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35429219 DOI: 10.1002/alz.12668 |
0.566 |
|
| 2022 |
Giorgio J, Jagust WJ, Baker S, Landau SM, Tino P, Kourtzi Z. A robust and interpretable machine learning approach using multimodal biological data to predict future pathological tau accumulation. Nature Communications. 13: 1887. PMID 35393421 DOI: 10.1038/s41467-022-28795-7 |
0.595 |
|
| 2022 |
Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ, Aarsland D, Alcolea D, Altomare D, von Arnim C, Baiardi S, Baldeiras I, Barthel H, Bateman RJ, ... ... Jagust WJ, et al. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. Jama Neurology. PMID 35099509 DOI: 10.1001/jamaneurol.2021.5216 |
0.755 |
|
| 2022 |
Ciampa CJ, Parent JH, Harrison TM, Fain RM, Betts MJ, Maass A, Winer JR, Baker SL, Janabi M, Furman DJ, D'Esposito M, Jagust WJ, Berry AS. Associations among locus coeruleus catecholamines, tau pathology, and memory in aging. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35034099 DOI: 10.1038/s41386-022-01269-6 |
0.843 |
|
| 2021 |
Adams JN, Harrison TM, Maass A, Baker SL, Jagust WJ. Distinct factors drive the spatiotemporal progression of tau pathology in older adults. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34965972 DOI: 10.1523/JNEUROSCI.1601-21.2021 |
0.694 |
|
| 2021 |
Ciampa CJ, Parent JH, Lapoint MR, Swinnerton KN, Taylor MM, Tennant VR, Whitman AJ, Jagust WJ, Berry AS. Elevated Dopamine Synthesis as a Mechanism of Cognitive Resilience in Aging. Cerebral Cortex (New York, N.Y. : 1991). PMID 34718454 DOI: 10.1093/cercor/bhab379 |
0.784 |
|
| 2021 |
Yoon B, Guo T, Provost K, Korman D, Ward TJ, Landau SM, Jagust WJ. Abnormal tau in amyloid PET negative individuals. Neurobiology of Aging. 109: 125-134. PMID 34715443 DOI: 10.1016/j.neurobiolaging.2021.09.019 |
0.601 |
|
| 2021 |
Guo T, Landau SM, Jagust WJ. Age, vascular disease, and Alzheimer's disease pathologies in amyloid negative elderly adults. Alzheimer's Research & Therapy. 13: 174. PMID 34654465 DOI: 10.1186/s13195-021-00913-5 |
0.644 |
|
| 2021 |
Tosun D, Demir Z, Veitch DP, Weintraub D, Aisen P, Jack CR, Jagust WJ, Petersen RC, Saykin AJ, Shaw LM, Trojanowski JQ, Weiner MW. Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34647694 DOI: 10.1002/alz.12480 |
0.353 |
|
| 2021 |
Tennant VR, Harrison TM, Adams JN, La Joie R, Winer JR, Jagust WJ. Fusiform gyrus phospho-tau is associated with failure of proper name retrieval in aging. Annals of Neurology. PMID 34590340 DOI: 10.1002/ana.26237 |
0.809 |
|
| 2021 |
Veitch DP, Weiner MW, Aisen PS, Beckett LA, DeCarli C, Green RC, Harvey D, Jack CR, Jagust W, Landau SM, Morris JC, Okonkwo O, Perrin RJ, Petersen RC, Rivera-Mindt M, et al. Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34581485 DOI: 10.1002/alz.12422 |
0.666 |
|
| 2021 |
Ziontz J, Adams JN, Harrison TM, Baker SL, Jagust WJ. Hippocampal connectivity with retrosplenial cortex is linked to neocortical tau accumulation and memory function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34531286 DOI: 10.1523/JNEUROSCI.0990-21.2021 |
0.377 |
|
| 2021 |
Risacher SL, West JD, Deardorff R, Gao S, Farlow MR, Brosch JR, Apostolova LG, McAllister TW, Wu YC, Jagust WJ, Landau SM, Weiner MW, Saykin AJ. Head injury is associated with tau deposition on PET in MCI and AD patients. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12230. PMID 34466653 DOI: 10.1002/dad2.12230 |
0.572 |
|
| 2021 |
Strom A, Iaccarino L, Edwards L, Lesman-Segev OH, Soleimani-Meigooni DN, Pham J, Baker SL, Landau S, Jagust WJ, Miller BL, Rosen HJ, Gorno-Tempini ML, Rabinovici GD, La Joie R. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease. Brain : a Journal of Neurology. PMID 34373896 DOI: 10.1093/brain/awab294 |
0.65 |
|
| 2021 |
Baker SL, Provost K, Thomas W, Whitman AJ, Janabi M, Schmidt ME, Timmers M, Kolb HC, Rabinovici GD, Jagust WJ. Evaluation of [F]-JNJ-64326067-AAA tau PET tracer in humans. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X211031035. PMID 34259071 DOI: 10.1177/0271678X211031035 |
0.352 |
|
| 2021 |
Ossenkoppele R, Smith R, Mattsson-Carlgren N, Groot C, Leuzy A, Strandberg O, Palmqvist S, Olsson T, Jögi J, Stormrud E, Cho H, Ryu YH, Choi JY, Boxer AL, Gorno-Tempini ML, ... ... Jagust WJ, et al. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging. Jama Neurology. PMID 34180956 DOI: 10.1001/jamaneurol.2021.1858 |
0.301 |
|
| 2021 |
Cassady KE, Adams JN, Chen X, Maass A, Harrison TM, Landau S, Baker S, Jagust W. Alzheimer's Pathology Is Associated with Dedifferentiation of Intrinsic Functional Memory Networks in Aging. Cerebral Cortex (New York, N.Y. : 1991). PMID 34037210 DOI: 10.1093/cercor/bhab122 |
0.782 |
|
| 2021 |
Royse SK, Minhas DS, Lopresti BJ, Murphy A, Ward T, Koeppe RA, Bullich S, DeSanti S, Jagust WJ, Landau SM. Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach. Alzheimer's Research & Therapy. 13: 99. PMID 33971965 DOI: 10.1186/s13195-021-00836-1 |
0.595 |
|
| 2021 |
Tosun D, Veitch D, Aisen P, Jack CR, Jagust WJ, Petersen RC, Saykin AJ, Bollinger J, Ovod V, Mawuenyega KG, Bateman RJ, Shaw LM, Trojanowski JQ, Blennow K, Zetterberg H, et al. Detection of β-amyloid positivity in Alzheimer's Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers. Brain Communications. 3: fcab008. PMID 33842885 DOI: 10.1093/braincomms/fcab008 |
0.314 |
|
| 2021 |
Adams JN, Maass A, Berron D, Harrison TM, Baker SL, Thomas WP, Stanfill M, Jagust WJ. Reduced repetition suppression in aging is driven by tau-related hyperactivity in medial temporal lobe. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33731446 DOI: 10.1523/JNEUROSCI.2504-20.2021 |
0.7 |
|
| 2021 |
Jagust WJ, Landau SM. Temporal Dynamics of Beta-amyloid Accumulation in Aging and Alzheimer's Disease. Neurology. PMID 33408147 DOI: 10.1212/WNL.0000000000011524 |
0.615 |
|
| 2020 |
Xia Y, Li L, Lockhart SN, Jagust WJ. Simultaneous Covariance Inference for Multimodal Integrative Analysis. Journal of the American Statistical Association. 115: 1279-1291. PMID 33867602 DOI: 10.1080/01621459.2019.1623040 |
0.551 |
|
| 2020 |
Harrison TM, Du R, Klencklen G, Baker SL, Jagust WJ. Distinct effects of beta-amyloid and tau on cortical thickness in cognitively healthy older adults. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33325068 DOI: 10.1002/alz.12249 |
0.345 |
|
| 2020 |
Sonni I, Lesman Segev OH, Baker SL, Iaccarino L, Korman D, Rabinovici GD, Jagust WJ, Landau SM, La Joie R. Evaluation of a visual interpretation method for tau-PET with F-flortaucipir. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12133. PMID 33313377 DOI: 10.1002/dad2.12133 |
0.591 |
|
| 2020 |
La Joie R, Visani AV, Lesman-Segev OH, Baker SL, Edwards L, Iaccarino L, Soleimani-Meigooni DN, Mellinger T, Janabi M, Miller ZA, Perry DC, Pham J, Strom A, Gorno-Tempini ML, Rosen HJ, ... ... Jagust WJ, et al. Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau- and amyloid-PET. Neurology. PMID 33262228 DOI: 10.1212/WNL.0000000000011270 |
0.375 |
|
| 2020 |
Lesman-Segev OH, La Joie R, Iaccarino L, Lobach I, Rosen HJ, Seo SW, Janabi M, Baker SL, Edwards L, Pham J, Olichney J, Boxer A, Huang E, Gorno-Tempini M, DeCarli C, ... ... Jagust WJ, et al. Diagnostic Accuracy of Amyloid versus FDG PET in Autopsy-Confirmed Dementia. Annals of Neurology. PMID 33219525 DOI: 10.1002/ana.25968 |
0.443 |
|
| 2020 |
Chen X, Cassady K, Adams JN, Harrison TM, Baker SL, Jagust WJ. Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33219003 DOI: 10.1523/JNEUROSCI.2111-20.2020 |
0.492 |
|
| 2020 |
Yoon B, Baker SL, Korman D, Tennant VR, Harrison TM, Landau S, Jagust WJ. Conscientiousness is associated with less amyloid deposition in cognitively normal aging. Psychology and Aging. 35: 993-999. PMID 33166168 DOI: 10.1037/pag0000582 |
0.832 |
|
| 2020 |
Soleimani-Meigooni DN, Iaccarino L, La Joie R, Baker S, Bourakova V, Boxer AL, Edwards L, Eser R, Gorno-Tempini ML, Jagust WJ, Janabi M, Kramer JH, Lesman-Segev OH, Mellinger T, Miller BL, et al. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases. Brain : a Journal of Neurology. PMID 33141172 DOI: 10.1093/brain/awaa276 |
0.385 |
|
| 2020 |
Guo T, Korman D, Baker SL, Landau SM, Jagust WJ. Longitudinal Cognitive and Biomarker Measurements Support a Unidirectional Pathway in Alzheimer's Disease Pathophysiology. Biological Psychiatry. PMID 32919611 DOI: 10.1016/J.Biopsych.2020.06.029 |
0.666 |
|
| 2020 |
Winer JR, Mander BA, Kumar S, Reed M, Baker SL, Jagust WJ, Walker MP. Sleep Disturbance Forecasts β-Amyloid Accumulation across Subsequent Years. Current Biology : Cb. PMID 32888482 DOI: 10.1016/J.Cub.2020.08.017 |
0.795 |
|
| 2020 |
Iaccarino L, La Joie R, Edwards L, Strom A, Schonhaut DR, Ossenkoppele R, Pham J, Mellinger T, Janabi M, Baker SL, Soleimani-Meigooni D, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer's Disease Continuum. Cerebral Cortex (New York, N.Y. : 1991). PMID 32808011 DOI: 10.1093/Cercor/Bhaa184 |
0.513 |
|
| 2020 |
Guo T, Korman D, La Joie R, Shaw LM, Trojanowski JQ, Jagust WJ, Landau SM. Normalization of CSF pTau measurement by Aβ improves its performance as a biomarker of Alzheimer's disease. Alzheimer's Research & Therapy. 12: 97. PMID 32799929 DOI: 10.1186/S13195-020-00665-8 |
0.659 |
|
| 2020 |
Guo T, Shaw LM, Trojanowski JQ, Jagust WJ, Landau SM. Association of CSF Aβ, amyloid PET and cognition in cognitively unimpaired elderly adults. Neurology. PMID 32759202 DOI: 10.1212/Wnl.0000000000010596 |
0.667 |
|
| 2020 |
Han JW, Maillard P, Harvey D, Fletcher E, Martinez O, Johnson DK, Olichney JM, Farias ST, Villeneuve S, Jagust W, Mungas D, DeCarli C. Association of vascular brain injury, neurodegeneration, amyloid and cognitive trajectory. Neurology. PMID 32732300 DOI: 10.1212/Wnl.0000000000010531 |
0.713 |
|
| 2020 |
Bejanin A, Tammewar G, Marx G, Cobigo Y, Iaccarino L, Kornak J, Staffaroni AM, Dickerson BC, Boeve BF, Knopman DS, Gorno-Tempini M, Miller BL, Jagust WJ, Boxer AL, Rosen HJ, et al. Longitudinal structural and metabolic changes in frontotemporal dementia. Neurology. PMID 32591470 DOI: 10.1212/Wnl.0000000000009760 |
0.368 |
|
| 2020 |
Raghavan NS, Dumitrescu L, Mormino E, Mahoney ER, Lee AJ, Gao Y, Bilgel M, Goldstein D, Harrison T, Engelman CD, Saykin AJ, Whelan CD, Liu JZ, Jagust W, Albert M, et al. Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease. Jama Neurology. PMID 32568366 DOI: 10.1001/Jamaneurol.2020.1760 |
0.593 |
|
| 2020 |
Ehrenberg AJ, Khatun A, Coomans E, Betts MJ, Capraro F, Thijssen EH, Senkevich K, Bharucha T, Jafarpour M, Young PNE, Jagust W, Carter SF, Lashley T, Grinberg LT, Pereira JB, et al. Correction to: Relevance of biomarkers across different neurodegenerative diseases. Alzheimer's Research & Therapy. 12: 71. PMID 32517788 DOI: 10.1186/S13195-020-00637-Y |
0.57 |
|
| 2020 |
Ehrenberg AJ, Khatun A, Coomans E, Betts MJ, Capraro F, Thijssen EH, Senkevich K, Bharucha T, Jafarpour M, Young PNE, Jagust W, Carter SF, Lashley T, Grinberg LT, Pereira JB, et al. Relevance of biomarkers across different neurodegenerative. Alzheimer's Research & Therapy. 12: 56. PMID 32404143 DOI: 10.1186/S13195-020-00601-W |
0.598 |
|
| 2020 |
Young PNE, Estarellas M, Coomans E, Srikrishna M, Beaumont H, Maass A, Venkataraman AV, Lissaman R, Jiménez D, Betts MJ, McGlinchey E, Berron D, O'Connor A, Fox NC, Pereira JB, ... Jagust W, et al. Imaging biomarkers in neurodegeneration: current and future practices. Alzheimer's Research & Therapy. 12: 49. PMID 32340618 DOI: 10.1186/S13195-020-00612-7 |
0.735 |
|
| 2020 |
Jagust WJ. Imaging Tau Pathology-The Next Step. Jama Neurology. PMID 32338712 DOI: 10.1001/jamaneurol.2020.0520 |
0.31 |
|
| 2020 |
Guo T, Landau SM, Jagust WJ. Detecting earlier stages of amyloid deposition using PET in cognitively normal elderly adults. Neurology. PMID 32188766 DOI: 10.1212/WNL.0000000000009216 |
0.665 |
|
| 2020 |
Ranasinghe KG, Cha J, Iaccarino L, Hinkley LB, Beagle AJ, Pham J, Jagust WJ, Miller BL, Rankin KP, Rabinovici GD, Vossel KA, Nagarajan SS. Neurophysiological signatures in Alzheimer's disease are distinctly associated with TAU, amyloid-β accumulation, and cognitive decline. Science Translational Medicine. 12. PMID 32161102 DOI: 10.1126/Scitranslmed.Aaz4069 |
0.488 |
|
| 2020 |
Giorgio J, Landau SM, Jagust WJ, Tino P, Kourtzi Z. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease. Neuroimage. Clinical. 26: 102199. PMID 32106025 DOI: 10.1016/j.nicl.2020.102199 |
0.662 |
|
| 2020 |
Korecka M, Figurski MJ, Landau SM, Brylska M, Alexander J, Blennow K, Zetterberg H, Jagust WJ, Trojanowski JQ, Shaw LM. Analytical and Clinical Performance of Amyloid-Beta Peptides Measurements in CSF of ADNIGO/2 Participants by an LC-MS/MS Reference Method. Clinical Chemistry. PMID 32087019 DOI: 10.1093/Clinchem/Hvaa012 |
0.649 |
|
| 2020 |
Pereira JB, Harrison TM, La Joie R, Baker SL, Jagust WJ. Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31915896 DOI: 10.1007/S00259-019-04669-X |
0.451 |
|
| 2020 |
La Joie R, Visani AV, Baker SL, Brown JA, Bourakova V, Cha J, Chaudhary K, Edwards L, Iaccarino L, Janabi M, Lesman-Segev OH, Miller ZA, Perry DC, O'Neil JP, Pham J, ... ... Jagust WJ, et al. Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET. Science Translational Medicine. 12. PMID 31894103 DOI: 10.1126/Scitranslmed.Aau5732 |
0.475 |
|
| 2019 |
Gallagher M, Okonkwo OC, Resnick SM, Jagust WJ, Benzinger TLS, Rapp PR. What are the threats to successful brain and cognitive aging? Neurobiology of Aging. 83: 130-134. PMID 31732016 DOI: 10.1016/J.Neurobiolaging.2019.04.016 |
0.432 |
|
| 2019 |
Harrison TM, Maass A, Adams JN, Du R, Baker SL, Jagust WJ. Tau deposition is associated with functional isolation of the hippocampus in aging. Nature Communications. 10: 4900. PMID 31653847 DOI: 10.1038/S41467-019-12921-Z |
0.688 |
|
| 2019 |
Adams JN, Maass A, Harrison TM, Baker SL, Jagust WJ. Cortical tau deposition follows patterns of entorhinal functional connectivity in aging. Elife. 8. PMID 31475904 DOI: 10.7554/Elife.49132 |
0.718 |
|
| 2019 |
Winer JR, Mander BA, Helfrich RF, Maass A, Harrison TM, Baker SL, Knight RT, Jagust WJ, Walker MP. Sleep as a potential biomarker of tau and β-amyloid burden in the human brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31209175 DOI: 10.1523/Jneurosci.0503-19.2019 |
0.81 |
|
| 2019 |
Leal SL, Ferguson LA, Harrison TM, Jagust WJ. Development of a mnemonic discrimination task using naturalistic stimuli with applications to aging and preclinical Alzheimer's disease. Learning & Memory (Cold Spring Harbor, N.Y.). 26: 219-228. PMID 31209116 DOI: 10.1101/lm.048967.118 |
0.784 |
|
| 2019 |
Maass A, Berron D, Harrison TM, Adams JN, La Joie R, Baker S, Mellinger T, Bell RK, Swinnerton K, Inglis B, Rabinovici GD, Düzel E, Jagust WJ. Alzheimer's pathology targets distinct memory networks in the ageing brain. Brain : a Journal of Neurology. PMID 31199481 DOI: 10.1093/Brain/Awz154 |
0.749 |
|
| 2019 |
Ossenkoppele R, Iaccarino L, Schonhaut DR, Brown JA, La Joie R, O'Neil JP, Janabi M, Baker SL, Kramer JH, Gorno-Tempini ML, Miller BL, Rosen HJ, Seeley WW, Jagust WJ, Rabinovici GD. Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain. Neuroimage. Clinical. 23: 101848. PMID 31077982 DOI: 10.1016/J.Nicl.2019.101848 |
0.425 |
|
| 2019 |
Baker SL, Harrison TM, Maaß A, La Joie R, Jagust W. Effect of off-target binding on F-Flortaucipir variability in healthy controls across the lifespan. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30877180 DOI: 10.2967/Jnumed.118.224113 |
0.677 |
|
| 2019 |
DeCarli C, Villeneuve S, Maillard P, Harvey D, Singh B, Carmichael O, Fletcher E, Olichney J, Farias S, Jagust W, Reed B, Mungas D. Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury. Journal of Alzheimer's Disease : Jad. PMID 30775991 DOI: 10.3233/Jad-180965 |
0.712 |
|
| 2019 |
Berry AS, White RL, Furman DJ, Naskolnakorn JR, Shah VD, D'Esposito M, Jagust WJ. Dopaminergic mechanisms underlying normal variation in trait anxiety. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30737306 DOI: 10.1523/JNEUROSCI.2382-18.2019 |
0.613 |
|
| 2019 |
Tsai RM, Bejanin A, Lesman-Segev O, LaJoie R, Visani A, Bourakova V, O'Neil JP, Janabi M, Baker S, Lee SE, Perry DC, Bajorek L, Karydas A, Spina S, Grinberg LT, ... ... Jagust W, et al. F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. Alzheimer's Research & Therapy. 11: 13. PMID 30704514 DOI: 10.1186/S13195-019-0470-7 |
0.445 |
|
| 2019 |
Jagust W, Jack CR, Bennett DA, Blennow K, Haeberlein SB, Holtzman DM, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, et al. "Alzheimer's disease" is neither "Alzheimer's clinical syndrome" nor "dementia". Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 15: 153-157. PMID 30642435 DOI: 10.1016/J.Jalz.2018.11.002 |
0.404 |
|
| 2019 |
Adams JN, Maass A, Harrison TM, Baker SL, Jagust WJ. Author response: Cortical tau deposition follows patterns of entorhinal functional connectivity in aging Elife. DOI: 10.7554/Elife.49132.026 |
0.312 |
|
| 2019 |
Xia Y, Li L, Lockhart SN, Jagust WJ. Simultaneous Covariance Inference for Multimodal Integrative Analysis Journal of the American Statistical Association. 115: 1279-1291. DOI: 10.1080/01621459.2019.1623040 |
0.534 |
|
| 2019 |
Guo T, Landau SM, Jagust WJ, Initiative ADN. Dt-01-03: Longitudinal Amyloid, Neurodegeneration And Cognition In Pre-Dementia Elderly Individuals With Different Atn Profiles Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.08.006 |
0.652 |
|
| 2019 |
Adams JN, Maass A, Harrison TM, Jagust WJ. O4-12-03: Cortical Tau Deposition Follows Patterns Of Entorhinal Functional Connectivity In Cognitively Normal Older Adults Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4808 |
0.371 |
|
| 2019 |
Harrison TM, Becerra M, Winer JR, Baker SL, Grothe MJ, Jagust WJ. O4-12-02: Tau Pathology And Cognition Are Related To Basal Forebrain Degeneration In Aging Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4807 |
0.386 |
|
| 2019 |
Maass A, Harrison TM, Berron D, Adams JN, Joie RL, Baker SL, Düzel E, Jagust WJ. F4-02-02: Tau Pet Imaging In Aging: Contributions To Cognitive Decline And Neural Dysfunction Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4719 |
0.414 |
|
| 2019 |
Thijssen E, Rojas JC, Joie RL, Dage J, Airey DC, Proctor N, Chai X, Sims JR, Bourakova V, Strom A, Karydas AM, Wang P, Heuer HW, Kramer JH, Miller BL, ... ... Jagust WJ, et al. O2-05-04: Plasma Ptau181 Levels Reflect [18F]Av1451 Tau Pet Uptake Across The Tauopathy Spectrum Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4478 |
0.312 |
|
| 2019 |
Mander BA, Winer JR, Jagust WJ, Walker MP. F2-08-02: LOCAL SLOW WAVE MEASURES DURING NREM SLOW WAVE SLEEP ACCURATELY TRACK β-AMYLOID STATUS Alzheimer's & Dementia. 15: P528-P529. DOI: 10.1016/J.Jalz.2019.06.4445 |
0.771 |
|
| 2019 |
Jagust WJ. Biological Consequences Of Subthreshold Amyloid Accumulation Alzheimers & Dementia. 15: 177. DOI: 10.1016/J.Jalz.2019.06.4374 |
0.353 |
|
| 2019 |
Baker SL, Joie RL, Liu C, Cobigo Y, Bourakova V, Harrison TM, Rabinovici GD, Jagust WJ. Ic-04-04: Iron, Neurodegeneration, Tau, And Amyloid In Patients With Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4154 |
0.373 |
|
| 2019 |
Soleimani-Meigooni DN, Iaccarino L, La Joie R, Lesman-Segev OH, Bourakova V, Strom A, Edwards L, Baker SL, Janabi M, Eser R, Larsen E, Spina S, Seeley WW, Grinberg LT, Jagust WJ, et al. P2-439: [18
F]FLORTAUCIPIR PET AND PATHOLOGY CORRELATIONS IN ALZHEIMER'S DISEASE, NON-ALZHEIMER'S TAUOPATHIES, AND OTHER NEURODEGENERATIVE DISEASES Alzheimer's & Dementia. 15: P782-P782. DOI: 10.1016/J.Jalz.2019.06.2846 |
0.433 |
|
| 2019 |
Berry AS, Harrison TM, Whitman A, Swinnerton KN, Tennant VR, Fenton LE, Hsu M, Jagust WJ. P2-423: THE INFLUENCE OF DOPAMINE SYNTHESIS CAPACITY ON REWARD LEARNING AND INCIDENTAL ENCODING IN AGING Alzheimer's & Dementia. 15: P773-P774. DOI: 10.1016/j.jalz.2019.06.2830 |
0.486 |
|
| 2019 |
Harrison TM, Adams JN, Maass A, Du R, Baker SL, Jagust WJ. P2-353: Signal Coherence In The Hippocampus Is Related To Its Functional Isolation, Preclinical Alzheimer'S Disease Pathology And Memory In Aging Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2760 |
0.393 |
|
| 2019 |
Iaccarino L, Schonhaut DR, La Joie R, Ossenkoppele R, Bejanin A, Edwards L, Tammewar G, Pham JQ, Chaudhary K, Janabi M, Baker SL, Miller BL, Jagust WJ, Rabinovici GD. P2-336: SPATIAL DISTRIBUTION AND TOPOGRAPHICAL RELATIONSHIPS OF PATHOLOGY AND NEURODEGENERATION IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P720-P721. DOI: 10.1016/J.Jalz.2019.06.2743 |
0.36 |
|
| 2019 |
Protas H, Goradia DD, Ghisays V, Luo J, VanGilder PS, Thiyyagura P, Malek-Ahmadi M, Lee W, Chen Y, Devadas V, Bauer R, Landau SM, Weiner MW, Jagust WJ, Chen K, et al. Ic-P-173: Individual-Based Network Analysis: A Novel Approach To Investigate The Pathological Spread Of Phf Tau Using Graph Theory In Clinical And Preclinical Stages Of Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.1023 |
0.592 |
|
| 2019 |
Giorgio J, Landau SM, Jagust WJ, Tino P, Kourtzi Z. PREDICTING FUTURE RATE OF COGNITIVE DECLINE DUE TO ALZHEIMER’S DISEASE Alzheimer's & Dementia. 15: P228. DOI: 10.1016/j.jalz.2019.06.026 |
0.603 |
|
| 2018 |
Harrison TM, La Joie R, Maass A, Baker SL, Swinnerton K, Fenton L, Mellinger TJ, Edwards L, Pham J, Miller BL, Rabinovici GD, Jagust WJ. Longitudinal tau accumulation and atrophy in aging and Alzheimer's disease. Annals of Neurology. PMID 30597624 DOI: 10.1002/Ana.25406 |
0.725 |
|
| 2018 |
Berry AS, Jagust WJ, Hsu M. Age-related variability in decision-making: Insights from neurochemistry. Cognitive, Affective & Behavioral Neuroscience. PMID 30536205 DOI: 10.3758/s13415-018-00678-9 |
0.52 |
|
| 2018 |
Schöll M, Maass A, Mattsson N, Ashton NJ, Blennow K, Zetterberg H, Jagust W. Biomarkers for tau pathology. Molecular and Cellular Neurosciences. PMID 30529601 DOI: 10.1016/J.Mcn.2018.12.001 |
0.763 |
|
| 2018 |
Joie R, Ayakta N, Seeley WW, Borys E, Boxer AL, DeCarli C, Doré V, Grinberg LT, Huang E, Hwang JH, Ikonomovic MD, Jack C, Jagust WJ, Jin LW, Klunk WE, et al. Multisite study of the relationships between antemortem [C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30347188 DOI: 10.1016/J.Jalz.2018.09.001 |
0.704 |
|
| 2018 |
Veitch DP, Weiner MW, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ, et al. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30321505 DOI: 10.1016/J.Jalz.2018.08.005 |
0.411 |
|
| 2018 |
Jagust W. Imaging the evolution and pathophysiology of Alzheimer disease. Nature Reviews Neuroscience. 19: 687-700. PMID 30266970 DOI: 10.1038/S41583-018-0067-3 |
0.493 |
|
| 2018 |
He M, Baker SL, Shah VD, Lockhart SN, Jagust WJ. Scan-time Corrections for 80-100 Minute Standardized Uptake Volume Ratios to Measure the 18F-AV-1451 Tracer for Tau Imaging. Ieee Transactions On Medical Imaging. PMID 30235119 DOI: 10.1109/Tmi.2018.2870441 |
0.619 |
|
| 2018 |
Li L, Kang J, Lockhart SN, Adams J, Jagust WJ. Spatially Adaptive Varying Correlation Analysis for Multimodal Neuroimaging Data. Ieee Transactions On Medical Imaging. PMID 30028695 DOI: 10.1109/Tmi.2018.2857221 |
0.631 |
|
| 2018 |
Mormino EC, Jagust WJ. A New Tool for Clinical Neuroscience-Synaptic Imaging. Jama Neurology. PMID 30014142 DOI: 10.1001/jamaneurol.2018.1643 |
0.517 |
|
| 2018 |
Adams JN, Lockhart SN, Li L, Jagust WJ. Relationships Between Tau and Glucose Metabolism Reflect Alzheimer's Disease Pathology in Cognitively Normal Older Adults. Cerebral Cortex (New York, N.Y. : 1991). PMID 29912295 DOI: 10.1093/Cercor/Bhy078 |
0.67 |
|
| 2018 |
Kim HJ, Park S, Cho H, Jang YK, San Lee J, Jang H, Kim Y, Kim KW, Ryu YH, Choi JY, Moon SH, Weiner MW, Jagust WJ, Rabinovici GD, DeCarli C, et al. Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging. Jama Neurology. PMID 29799981 DOI: 10.1001/Jamaneurol.2018.0975 |
0.6 |
|
| 2018 |
Berry AS, Shah VD, Jagust WJ. The Influence of Dopamine on Cognitive Flexibility Is Mediated by Functional Connectivity in Young but Not Older Adults. Journal of Cognitive Neuroscience. 1-15. PMID 29791298 DOI: 10.1162/jocn_a_01286 |
0.554 |
|
| 2018 |
Leal SL, Lockhart SN, Maass A, Bell RK, Jagust WJ. Subthreshold amyloid predicts tau deposition in aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29686045 DOI: 10.1523/Jneurosci.0485-18.2018 |
0.85 |
|
| 2018 |
Harrison TM, Maass A, Baker SL, Jagust WJ. Brain morphology, cognition, and β-amyloid in older adults with superior memory performance. Neurobiology of Aging. 67: 162-170. PMID 29665578 DOI: 10.1016/J.Neurobiolaging.2018.03.024 |
0.7 |
|
| 2018 |
Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 14: 535-562. PMID 29653606 DOI: 10.1016/J.Jalz.2018.02.018 |
0.476 |
|
| 2018 |
Mattsson N, Groot C, Jansen WJ, Landau S, Villemagne V, Engelborghs S, Mintun M, Lleo A, Molinuevo JL, Jagust W, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, et al. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29601787 DOI: 10.1016/J.Jalz.2018.02.009 |
0.701 |
|
| 2018 |
Landau SM, Horng A, Jagust WJ. Memory decline accompanies subthreshold amyloid accumulation. Neurology. PMID 29572282 DOI: 10.1212/WNL.0000000000005354 |
0.663 |
|
| 2018 |
Arnemann KL, Stöber F, Narayan S, Rabinovici GD, Jagust WJ. Metabolic brain networks in aging and preclinical Alzheimer's disease. Neuroimage. Clinical. 17: 987-999. PMID 29527500 DOI: 10.1016/j.nicl.2017.12.037 |
0.429 |
|
| 2018 |
Sescousse G, Ligneul R, van Holst RJ, Janssen LK, de Boer F, Janssen M, Berry AS, Jagust WJ, Cools R. Spontaneous eye blink rate and dopamine synthesis capacity: Preliminary evidence for an absence of positive correlation. The European Journal of Neuroscience. PMID 29514419 DOI: 10.1111/Ejn.13895 |
0.522 |
|
| 2018 |
Jagust W. Following the pathway to Alzheimer's disease. Nature Neuroscience. 21: 306-308. PMID 29476126 DOI: 10.1038/S41593-018-0085-5 |
0.395 |
|
| 2018 |
Santos-Santos MA, Rabinovici GD, Iaccarino L, Ayakta N, Tammewar G, Lobach I, Henry ML, Hubbard I, Mandelli ML, Spinelli E, Miller ZA, Pressman PS, O'Neil JP, Ghosh P, Lazaris A, ... ... Jagust WJ, et al. Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia. Jama Neurology. PMID 29309493 DOI: 10.1001/Jamaneurol.2017.4309 |
0.315 |
|
| 2018 |
Iaccarino L, Tammewar G, Ayakta N, Baker SL, Bejanin A, Boxer AL, Gorno-Tempini ML, Janabi M, Kramer JH, Lazaris A, Lockhart SN, Miller BL, Miller ZA, O'Neil JP, Ossenkoppele R, ... ... Jagust WJ, et al. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease. Neuroimage. Clinical. 17: 452-464. PMID 29159058 DOI: 10.1016/J.Nicl.2017.09.016 |
0.689 |
|
| 2018 |
Leal SL, Jagust WJ. P2-083: The Influence Of Aging And Tau Deposition On Memory Consolidation Using A Novel Ecologically Valid Memory Task Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.768 |
0.73 |
|
| 2018 |
Jagust WJ. F5-03-03: Resistance To Ad Over The Lifecourse Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2978 |
0.324 |
|
| 2018 |
Harrison TM, Joie RL, Maass A, Baker SL, Rabinovici GD, Jagust WJ. O4-09-04: Longitudinal Tau-Pet And Atrophy In Healthy Older Adults And In Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2960 |
0.418 |
|
| 2018 |
Harrison TM, Joie RL, Maass A, Baker SL, Rabinovici GD, Jagust WJ. Ic-P-205: Longitudinal Tau-Pet And Atrophy In Healthy Older Adults And Those With Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2272 |
0.419 |
|
| 2018 |
Maass A, Berron D, Harrison TM, Baker SL, Mellinger TJ, Swinnerton KN, Bell RK, Düzel E, Jagust WJ, Adams JN. F1-04-04: Effects Of Tau And Amyloid Deposition Measured By Pet On Domain-Specific Memory Function In Old Age Alzheimers & Dementia. 14: 87. DOI: 10.1016/J.Jalz.2018.06.2167 |
0.403 |
|
| 2018 |
Chen K, Lee W, Jagust WJ, Weiner M, Reiman EM. Ic-P-003: Relationships Between Mean Cortical Amyloid Burden And Regional Gray Matter Reductions In Alzheimer'S Dementia, Mild Cognitive Impairment And Unimpaired Older Adults Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2067 |
0.458 |
|
| 2018 |
Sonni I, Lesman-Segev OH, Maass A, Baker SL, Korman D, Rabinovici GD, Jagust WJ. P2-373: Evaluation Of Visual Interpretation Methods For Tau Pet Imaging Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1064 |
0.311 |
|
| 2018 |
Sescousse G, Ligneul R, van Holst R, Janssen L, de Boer F, Janssen M, Berry A, Jagust W, Cools R. F180. Spontaneous Eye Blink Rate: A Good Proxy for Dopamine? Biological Psychiatry. 83: S308-S309. DOI: 10.1016/J.Biopsych.2018.02.794 |
0.484 |
|
| 2018 |
van Holst R, Sescousse G, Timmeren T, Ouden Hd, Berry A, Jagust W, Cools R. S258. Dorsal, but Not Ventral Striatal Dopamine Mediates the Effect of Gambling Disorder on Compulsivity During Reversal Learning Biological Psychiatry. 83: S448-S449. DOI: 10.1016/j.biopsych.2018.02.1150 |
0.474 |
|
| 2017 |
La Joie R, Bejanin A, Fagan AM, Ayakta N, Baker SL, Bourakova V, Boxer AL, Cha J, Karydas A, Jerome G, Maass A, Mensing A, Miller ZA, O'Neil JP, Pham J, ... ... Jagust WJ, et al. Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample. Neurology. PMID 29282337 DOI: 10.1212/Wnl.0000000000004860 |
0.678 |
|
| 2017 |
Helfrich RF, Mander BA, Jagust WJ, Knight RT, Walker MP. Old Brains Come Uncoupled in Sleep: Slow Wave-Spindle Synchrony, Brain Atrophy, and Forgetting. Neuron. PMID 29249289 DOI: 10.1016/J.Neuron.2017.11.020 |
0.791 |
|
| 2017 |
Winer JR, Maass A, Pressman P, Stiver J, Schonhaut DR, Baker SL, Kramer J, Rabinovici GD, Jagust WJ. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease. Jama Neurology. PMID 29228071 DOI: 10.1001/Jamaneurol.2017.3713 |
0.704 |
|
| 2017 |
Maass A, Lockhart SN, Harrison TM, Bell RK, Mellinger T, Swinnerton K, Baker SL, Rabinovici GD, Jagust WJ. Entorhinal tau pathology, episodic memory decline and neurodegeneration in aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29192126 DOI: 10.1523/Jneurosci.2028-17.2017 |
0.813 |
|
| 2017 |
Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, ... ... Jagust WJ, et al. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. Jama Psychiatry. PMID 29188296 DOI: 10.1001/Jamapsychiatry.2017.3391 |
0.727 |
|
| 2017 |
Jang YK, Lyoo CH, Park S, Oh SJ, Cho H, Oh M, Ryu YH, Choi JY, Rabinovici GD, Kim HJ, Moon SH, Jang H, Lee JS, Jagust WJ, Na DL, et al. Head to head comparison of [(18)F] AV-1451 and [(18)F] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29143870 DOI: 10.1007/S00259-017-3876-0 |
0.434 |
|
| 2017 |
Baker SL, Maass A, Jagust WJ. Considerations and code for partial volume correcting [(18)F]-AV-1451 tau PET data. Data in Brief. 15: 648-657. PMID 29124088 DOI: 10.1016/J.Dib.2017.10.024 |
0.682 |
|
| 2017 |
Palmqvist S, Schöll M, Strandberg O, Mattsson N, Stomrud E, Zetterberg H, Blennow K, Landau S, Jagust W, Hansson O. Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nature Communications. 8: 1214. PMID 29089479 DOI: 10.1038/S41467-017-01150-X |
0.758 |
|
| 2017 |
Mander BA, Zhu AH, Lindquist JR, Villeneuve S, Rao V, Lu B, Saletin JM, Ancoli-Israel S, Jagust W, Walker MP. White matter structure in older adults moderates the benefit of sleep spindles on motor memory consolidation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29084867 DOI: 10.1523/Jneurosci.3033-16.2017 |
0.784 |
|
| 2017 |
Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, Ayakta N, Cantwell A, Janabi M, Lauriola M, O'Neil JP, Gorno-Tempini ML, Miller ZA, Rosen HJ, Miller BL, ... Jagust WJ, et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease. Brain : a Journal of Neurology. PMID 29053874 DOI: 10.1093/Brain/Awx243 |
0.524 |
|
| 2017 |
Vogel JW, Varga Doležalová M, La Joie R, Marks SM, Schwimmer HD, Landau SM, Jagust WJ. Subjective cognitive decline and β-amyloid burden predict cognitive change in healthy elderly. Neurology. PMID 28986416 DOI: 10.1212/WNL.0000000000004627 |
0.639 |
|
| 2017 |
Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD, Tsai R, Winer J, Russell DS, Litvan I, Roberson ED, Seeley WW, Grinberg LT, Kramer JH, Miller BL, ... ... Jagust WJ, et al. (18) F-flortaucipir tau PET distinguishes established progressive supranuclear palsy from controls and Parkinson's disease: A multicenter study. Annals of Neurology. PMID 28980714 DOI: 10.1002/Ana.25060 |
0.371 |
|
| 2017 |
Ossenkoppele R, Jagust WJ. The Complexity of Subjective Cognitive Decline. Jama Neurology. PMID 28973114 DOI: 10.1001/jamaneurol.2017.2224 |
0.322 |
|
| 2017 |
Berry AS, Shah VD, Furman DJ, White RL, Baker SL, O'Neil JP, Janabi M, D'Esposito M, Jagust WJ. Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but not Dopamine Release. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28816243 DOI: 10.1038/Npp.2017.180 |
0.603 |
|
| 2017 |
van Holst RJ, Sescousse G, Janssen LK, Janssen M, Berry AS, Jagust WJ, Cools R. Increased Striatal Dopamine Synthesis Capacity in Gambling Addiction. Biological Psychiatry. PMID 28728675 DOI: 10.1016/J.Biopsych.2017.06.010 |
0.504 |
|
| 2017 |
Maass A, Landau S, Baker SL, Horng A, Lockhart SN, Joie R, Rabinovici GD, Jagust WJ. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's Disease. Neuroimage. PMID 28587897 DOI: 10.1016/J.Neuroimage.2017.05.058 |
0.851 |
|
| 2017 |
Insel PS, Ossenkoppele R, Gessert D, Jagust W, Landau S, Hansson O, Weiner MW, Mattsson N. Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease. Frontiers in Neuroscience. 11: 281. PMID 28567001 DOI: 10.3389/Fnins.2017.00281 |
0.693 |
|
| 2017 |
Liu CY, Ohki Y, Tomita T, Osawa S, Reed BR, Jagust W, Berlo VV, Jin LW, Chui HC, Coppola G, Ringman JM. Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 28550247 DOI: 10.3233/JAD-161203 |
0.587 |
|
| 2017 |
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ, et al. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28342697 DOI: 10.1016/J.Jalz.2016.11.007 |
0.376 |
|
| 2017 |
Tosun D, Landau S, Aisen PS, Petersen RC, Mintun M, Jagust W, Weiner MW. Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals. Brain : a Journal of Neurology. PMID 28334939 DOI: 10.1093/Brain/Awx046 |
0.68 |
|
| 2017 |
Schreiber S, Schreiber F, Lockhart SN, Horng A, Bejanin A, Landau SM, Jagust WJ. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology. Jama Neurology. PMID 28319241 DOI: 10.1001/Jamaneurol.2016.5349 |
0.771 |
|
| 2017 |
Lockhart SN, Schöll M, Baker SL, Ayakta N, Swinnerton KN, Bell RK, Mellinger TJ, Shah VD, O'Neil JP, Janabi M, Jagust WJ. Amyloid and Tau PET Demonstrate Region-Specific Associations in Normal Older People. Neuroimage. PMID 28232190 DOI: 10.1016/J.Neuroimage.2017.02.051 |
0.768 |
|
| 2017 |
Marks SM, Lockhart SN, Baker SL, Jagust WJ. Tau and β-amyloid are associated with medial temporal lobe structure, function and memory encoding in normal aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28213439 DOI: 10.1523/Jneurosci.3769-16.2017 |
0.699 |
|
| 2017 |
Lockhart SN, Ayakta N, Winer JR, La Joie R, Rabinovici GD, Jagust WJ. Elevated (18)F-AV-1451 PET tracer uptake detected in incidental imaging findings. Neurology. PMID 28188303 DOI: 10.1212/Wnl.0000000000003724 |
0.669 |
|
| 2017 |
Leal SL, Landau SM, Bell RK, Jagust WJ. Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline. Elife. 6. PMID 28177283 DOI: 10.7554/eLife.22978 |
0.831 |
|
| 2017 |
Spina S, Schonhaut DR, Boeve BF, Seeley WW, Ossenkoppele R, O'Neil JP, Lazaris A, Rosen HJ, Boxer AL, Perry DC, Miller BL, Dickson DW, Parisi JE, Jagust WJ, Murray ME, et al. Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations. Neurology. PMID 28130473 DOI: 10.1212/Wnl.0000000000003636 |
0.386 |
|
| 2017 |
Seo SW, Ayakta N, Grinberg LT, Villeneuve S, Lehmann M, Reed B, DeCarli C, Miller BL, Rosen HJ, Boxer AL, O'Neil JP, Jin LW, Seeley WW, Jagust WJ, Rabinovici GD. Regional correlations between [(11)C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort. Neuroimage. Clinical. 13: 130-137. PMID 27981028 DOI: 10.1016/J.Nicl.2016.11.008 |
0.695 |
|
| 2017 |
Leal SL, Landau SM, Bell RK, Jagust WJ. Author response: Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline Elife. DOI: 10.7554/Elife.22978.012 |
0.806 |
|
| 2017 |
Harrison TM, Lockhart SN, Baker SL, Jagust WJ. THE ROLE OF β-AMYLOID IN SUPERAGERS WITH SUPERIOR MEMORY PERFORMANCE AND PRESERVED BRAIN MORPHOMETRY Alzheimer's & Dementia. 13: P1463-P1464. DOI: 10.1016/J.Jalz.2017.07.532 |
0.622 |
|
| 2017 |
Jagust WJ. Neural Activity Revealed With Fmri Is Related To Beta-Amyloid And Tau Deposition In Healthy Aging Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.389 |
0.346 |
|
| 2017 |
Jagust WJ, Landau SM. PET IMAGING THROUGH THE COURSE OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 13: P878. DOI: 10.1016/j.jalz.2017.07.263 |
0.629 |
|
| 2017 |
Jack CR, Jagust WJ, McDade E, Blennow K. Opportunities And Challenges For Implementing Alzheimers Biomarkers In Research Studies Alzheimers & Dementia. 13: 878. DOI: 10.1016/J.Jalz.2017.07.262 |
0.33 |
|
| 2017 |
Lockhart SN, Adams JN, Baker SL, Kang J, Li L, Jagust WJ. EFFECTS OF TAU DEPOSITION ON CEREBRAL GLUCOSE METABOLISM IN NORMAL OLDER ADULTS VARY BY AMYLOID LEVEL Alzheimer's & Dementia. 13: P202. DOI: 10.1016/J.Jalz.2017.07.066 |
0.625 |
|
| 2017 |
La Joie R, Visani A, Bourakova V, Baker SL, Ayakta N, Pham J, Mensing A, Rosen H, Miller BL, Jagust WJ, Rabinovici GD. [IC-01-01]: AV1451-PET CORTICAL UPTAKE AND REGIONAL DISTRIBUTION PREDICTS LONGITUDINAL ATROPHY IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P1-P1. DOI: 10.1016/J.Jalz.2017.06.2621 |
0.381 |
|
| 2017 |
Lockhart SN, Maass A, Marks SM, Baker SL, Jagust WJ. ASSOCIATIONS BETWEEN HIPPOCAMPAL AV-1451 DEPOSITION AND LIMBIC WHITE MATTER INTEGRITY IN NORMAL AGING Alzheimer's & Dementia. 13: P140. DOI: 10.1016/J.Jalz.2017.06.2565 |
0.591 |
|
| 2017 |
La Joie R, Bejanin A, Fagan AM, Ayakta N, Baker SL, Bourakova V, Karydas A, Jerome G, O'Neil JP, Pham J, Visani A, Rosen H, Boxer A, Miller BL, Jagust WJ, et al. AV1451-PET UPTAKE AND CSF BIOMARKERS IN A HETEROGENEOUS CLINICAL SAMPLE: TWO SIDES OF THE SAME COIN? Alzheimer's & Dementia. 13: P137-P138. DOI: 10.1016/J.Jalz.2017.06.2561 |
0.304 |
|
| 2017 |
Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, Ayakta N, Cantwell A, Janabi M, Lauriola M, O'Neil JP, Gorno-Tempini M, Miller ZA, Rosen HJ, Miller BL, ... Jagust WJ, et al. [IC-P-176]: TAU PATHOLOGY AND GRAY MATTER ATROPHY CONTRIBUTE TO COGNITIVE IMPAIRMENT IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P131-P131. DOI: 10.1016/J.Jalz.2017.06.2551 |
0.447 |
|
| 2017 |
Maass A, Lockhart SN, Mellinger TJ, Bell RK, Baker SL, Jagust WJ. [IC-P-124]: MEDIAL TEMPORAL LOBE TAU IS STRONGLY RELATED TO EPISODIC MEMORY DECLINE IN AGING Alzheimer's & Dementia. 13: P94-P95. DOI: 10.1016/J.Jalz.2017.06.2398 |
0.62 |
|
| 2017 |
La Joie R, Bourakova V, Visani A, Bejanin A, Ayakta N, Baker SL, Karydas A, Coppola G, Mensing A, Pham J, Rosen H, Miller BL, Jagust WJ, Rabinovici GD. [IC-P-059]: DOES APOE-ε4 HAVE AN Aβ-INDEPENDENT EFFECT ON TAU PATHOLOGY? NEUROIMAGING INVESTIGATIONS IN COGNITIVELY NORMAL ELDERS AND PATIENTS WITH ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P48-P49. DOI: 10.1016/J.Jalz.2017.06.2332 |
0.465 |
|
| 2017 |
Reiman EM, Kuang X, Luo J, Chen Y, Thiyyagura P, Bauer R, Lee W, Protas H, Goradia DD, Aisen PS, Johnson K, Langbaum JB, Sperling RA, Tariot P, Jagust WJ, et al. [IC-P-041]: SAMPLE SIZES FOR 24-MONTH ALZHEIMER's PREVENTION TRIALS USING BIOMARKER ENDPOINTS IN COGNITIVELY UNIMPAIRED AMYLOID-POSITIVE ADULTS Alzheimer's & Dementia. 13: P36-P37. DOI: 10.1016/J.Jalz.2017.06.2313 |
0.402 |
|
| 2017 |
Landau SM, Jagust WJ. [IC-P-013]: AMYLOID ACCUMULATION WITHIN THE NEGATIVE RANGE IS LINKED TO MEMORY DECLINE IN COGNITIVELY NORMAL OLDER INDIVIDUALS Alzheimer's & Dementia. 13: P17-P18. DOI: 10.1016/j.jalz.2017.06.2285 |
0.636 |
|
| 2017 |
Jang YK, Lyoo CH, Rabinovici GD, Oh SJ, Cho H, Oh M, Ryu YH, Park S, Kim HJ, Moon SH, Jagust WJ, Na DL, Kim JS, Seo SW. [P4-212]: HEAD-TO-HEAD COMPARISON OF [18
F] AV-1451 AND [18
F] THK5351 FOR TAU IMAGING IN ALZHEIMER's DISEASE AND FRONTOTEMPORAL DEMENTIA Alzheimer's & Dementia. 13: P1347-P1348. DOI: 10.1016/J.Jalz.2017.06.2080 |
0.384 |
|
| 2017 |
Insel P, Ossenkoppele R, Gessert D, Jagust WJ, Landau SM, Hansson O, Weiner M, Mattsson N. Emerging Amyloid Pathology Alzheimers & Dementia. 13: 1340. DOI: 10.1016/J.Jalz.2017.06.2064 |
0.609 |
|
| 2017 |
Baker SL, Lockhart SN, Maass A, Jagust WJ. [P4-052]: PARTIAL VOLUME EFFECTS AND MEDIAL TEMPORAL LOBE TAU QUANTITATION WITH PET Alzheimer's & Dementia. 13: P1277-P1277. DOI: 10.1016/J.Jalz.2017.06.1917 |
0.624 |
|
| 2017 |
Goradia DD, Chen K, Chen Y, Snyder N, Harvey D, Landau SM, Jagust WJ, Weiner M, Reiman EM. [P3–032]: Ssri Use Associated With Reduced Amyloid Burden In Persons With Combat‐Related Ptsd: Preliminary Findings From Adni‐Dod Alzheimers & Dementia. 13: 942. DOI: 10.1016/J.Jalz.2017.06.1845 |
0.578 |
|
| 2017 |
van Holst R, Sescousse G, Janssen L, Janssen M, Berry A, Jagust W, Cools R. 195. Increased Dopamine Synthesis Capacity in Gambling Addiction Predicts Drug-Induced Enhances in Reward Learning Biological Psychiatry. 81: S81. DOI: 10.1016/J.Biopsych.2017.02.208 |
0.465 |
|
| 2016 |
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Salazar J, Saykin AJ, Shaw LM, Toga AW, et al. The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27931796 DOI: 10.1016/J.Jalz.2016.10.006 |
0.398 |
|
| 2016 |
Berry AS, Shah VD, Baker SL, Vogel JW, O'Neil JP, Janabi M, Schwimmer HD, Marks SM, Jagust WJ. Aging affects dopaminergic neural mechanisms of cognitive flexibility. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 27807030 DOI: 10.1523/Jneurosci.0626-16.2016 |
0.581 |
|
| 2016 |
Tosun D, Schuff N, Rabinovici GD, Ayakta N, Miller BL, Jagust W, Kramer J, Weiner MM, Rosen HJ. Diagnostic utility of ASL-MRI and FDG-PET in the behavioral variant of FTD and AD. Annals of Clinical and Translational Neurology. 3: 740-751. PMID 27752510 DOI: 10.1002/Acn3.330 |
0.415 |
|
| 2016 |
Babiloni C, Del Percio C, Caroli A, Salvatore E, Nicolai E, Marzano N, Lizio R, Cavedo E, Landau S, Chen K, Jagust W, Reiman E, Tedeschi G, Montella P, De Stefano M, et al. Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer's disease: an EEG-PET study. Neurobiology of Aging. 48: 122-134. PMID 27668356 DOI: 10.1016/j.neurobiolaging.2016.08.021 |
0.596 |
|
| 2016 |
Baker SL, Lockhart SN, Price JC, He M, Huesman RH, Schonhaut D, Faria J, Rabinovici G, Jagust WJ. Reference tissue-based kinetic evaluation of 18F-AV-1451 in aging and dementia. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27587706 DOI: 10.2967/Jnumed.116.175273 |
0.693 |
|
| 2016 |
Yassine HN, Feng Q, Azizkhanian I, Rawat V, Castor K, Fonteh AN, Harrington MG, Zheng L, Reed BR, DeCarli C, Jagust WJ, Chui HC. Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis. Jama Neurology. PMID 27532692 DOI: 10.1001/Jamaneurol.2016.1924 |
0.489 |
|
| 2016 |
Jagust W. Tau and β-Amyloid-The Malignant Duo. Jama Neurology. 73: 1049-1050. PMID 27454015 DOI: 10.1001/Jamaneurol.2016.2481 |
0.339 |
|
| 2016 |
Jagust WJ. Early life sets the stage for aging. Proceedings of the National Academy of Sciences of the United States of America. PMID 27436907 DOI: 10.1073/pnas.1609720113 |
0.369 |
|
| 2016 |
Ballarini T, Iaccarino L, Magnani G, Ayakta N, Miller BL, Jagust WJ, Gorno-Tempini ML, D Rabinovici G, Perani D. Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease. Human Brain Mapping. PMID 27412866 DOI: 10.1002/Hbm.23305 |
0.369 |
|
| 2016 |
Jack CR, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, Hampel H, Jagust WJ, Johnson KA, Knopman DS, Petersen RC, Scheltens P, Sperling RA, Dubois B. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. PMID 27371494 DOI: 10.1212/Wnl.0000000000002923 |
0.445 |
|
| 2016 |
Chételat G, Ossenkoppele R, Villemagne VL, Perrotin A, Landeau B, Mézenge F, Jagust WJ, Dore V, Miller BL, Egret S, Seeley WW, van der Flier WM, La Joie R, Ames D, van Berckel BN, et al. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. Brain : a Journal of Neurology. PMID 27357349 DOI: 10.1093/Brain/Aww159 |
0.452 |
|
| 2016 |
Lockhart SN, Baker SL, Okamura N, Furukawa K, Ishiki A, Furumoto S, Tashiro M, Yanai K, Arai H, Kudo Y, Harada R, Tomita N, Hiraoka K, Watanuki S, Jagust WJ. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351. Plos One. 11: e0158460. PMID 27355840 DOI: 10.1371/Journal.Pone.0158460 |
0.691 |
|
| 2016 |
Mander BA, Winer J, Jagust WJ, Walker MP. Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease? Trends in Neurosciences. PMID 27325209 DOI: 10.1016/J.Tins.2016.05.002 |
0.802 |
|
| 2016 |
Oh H, Madison C, Baker S, Rabinovici G, Jagust W. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease. Brain : a Journal of Neurology. PMID 27190008 DOI: 10.1093/Brain/Aww108 |
0.743 |
|
| 2016 |
Insel PS, Mattsson N, Mackin RS, Schöll M, Nosheny RL, Tosun D, Donohue MC, Aisen PS, Jagust WJ, Weiner MW. Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology. Neurology. PMID 27164667 DOI: 10.1212/Wnl.0000000000002683 |
0.633 |
|
| 2016 |
Fletcher E, Villeneuve S, Maillard P, Harvey D, Reed B, Jagust W, DeCarli C. β-amyloid, hippocampal atrophy and their relation to longitudinal brain change in cognitively normal individuals. Neurobiology of Aging. 40: 173-80. PMID 26973117 DOI: 10.1016/J.Neurobiolaging.2016.01.133 |
0.721 |
|
| 2016 |
Schreiber S, Vogel J, Schwimmer HD, Marks SM, Schreiber F, Jagust W. Impact of lifestyle dimensions on brain pathology and cognition. Neurobiology of Aging. 40: 164-172. PMID 26973116 DOI: 10.1016/j.neurobiolaging.2016.01.012 |
0.302 |
|
| 2016 |
Schreiber S, Vogel J, Schwimmer HD, Marks SM, Schreiber F, Jagust W. Impact of lifestyle dimensions on brain pathology and cognition. Neurobiology of Aging. 40: 164-172. PMID 26973116 DOI: 10.1016/j.neurobiolaging.2016.01.012 |
0.302 |
|
| 2016 |
Landau SM, Horng A, Fero A, Jagust WJ. Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI. Neurology. PMID 26968515 DOI: 10.1212/WNL.0000000000002576 |
0.68 |
|
| 2016 |
Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL, O'Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, ... ... Jagust WJ, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain : a Journal of Neurology. PMID 26962052 DOI: 10.1093/Brain/Aww027 |
0.793 |
|
| 2016 |
Schöll M, Lockhart SN, Schonhaut DR, O'Neil JP, Janabi M, Ossenkoppele R, Baker SL, Vogel JW, Faria J, Schwimmer HD, Rabinovici GD, Jagust WJ. PET Imaging of Tau Deposition in the Aging Human Brain. Neuron. 89: 971-82. PMID 26938442 DOI: 10.1016/J.Neuron.2016.01.028 |
0.801 |
|
| 2016 |
Jung NY, Han CE, Kim HJ, Yoo SW, Kim HJ, Kim EJ, Na DL, Lockhart SN, Jagust WJ, Seong JK, Seo SW. Tract-Specific Correlates of Neuropsychological Deficits in Patients with Subcortical Vascular Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 26836179 DOI: 10.3233/Jad-150841 |
0.638 |
|
| 2016 |
Jack CR, Knopman DS, Chételat G, Dickson D, Fagan AM, Frisoni GB, Jagust W, Mormino EC, Petersen RC, Sperling RA, van der Flier WM, Villemagne VL, Visser PJ, Vos SJ. Suspected non-Alzheimer disease pathophysiology - concept and controversy. Nature Reviews. Neurology. PMID 26782335 DOI: 10.1038/Nrneurol.2015.251 |
0.653 |
|
| 2016 |
Jagust W. Is amyloid-β harmful to the brain? Insights from human imaging studies Brain. 139: 23-30. PMID 26614753 DOI: 10.1093/Brain/Awv326 |
0.462 |
|
| 2016 |
Jagust W. Relationships between tau deposition, cognition, and β-amyloid Neurobiology of Aging. 39. DOI: 10.1016/J.Neurobiolaging.2016.01.022 |
0.411 |
|
| 2016 |
Winer JR, Mander BA, Lockhart SN, Schöll M, Saletin JM, Lu BS, Ancoli-Israel S, Jagust WJ, Walker MP. O4-09-01: An Nrem Sleep Signature of Human in Vivo TAU Burden Alzheimer's & Dementia. 12: P353-P353. DOI: 10.1016/J.Jalz.2016.06.654 |
0.77 |
|
| 2016 |
Ossenkoppele R, Schonhaut DR, Brown J, O'Neil JP, Janabi M, Baker SL, Schöll M, Kramer J, Gorno Tempini M, Miller B, Seeley WW, Jagust WJ, Rabinovici GD. O3-08-04: Tau Covariance Patterns in Alzheimer's Disease Patients Resemble Intrinsic Connectivity Networks in Young Adults Alzheimer's & Dementia. 12: P305-P306. DOI: 10.1016/J.Jalz.2016.06.552 |
0.356 |
|
| 2016 |
Jagust WJ. How Ad-Specific Are Ab And Tau Imaging Biomarkers? Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.281 |
0.381 |
|
| 2016 |
Risacher SL, Deters K, Schwarz AJ, Shcherbinin S, West JD, Jagust WJ, Jack CR, Weiner MW, Saykin AJ. Relationship Between [18F]Av-1451 Binding And Antecedent Amyloid Deposition, Glucose Hypometabolism And Atrophy Measures: Preliminary Analysis In The Adni Cohort Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.237 |
0.329 |
|
| 2016 |
Lockhart SN, Schöll M, Mellinger TJ, Swinnerton KN, Bell RK, O'Neil JP, Janabi M, Baker SL, Jagust WJ. IC-P-193: Examining Amyloid and TAU Inter-Regional PET Association Patterns in Cognitively Normal Older Adults Alzheimer's & Dementia. 12: P139-P140. DOI: 10.1016/J.Jalz.2016.06.224 |
0.675 |
|
| 2016 |
Ossenkoppele R, Schonhaut DR, Brown J, O'Neil JP, Janabi M, Baker SL, Schöll M, Kramer J, Gorno Tempini M, Miller B, Seeley WW, Jagust WJ, Rabinovici GD. IC-P-192: TAU Covariance Patterns in ad Patients Resemble Intrinsic Connectivity Networks in Young Adults Alzheimer's & Dementia. 12: P138-P139. DOI: 10.1016/J.Jalz.2016.06.223 |
0.342 |
|
| 2016 |
Mellinger TJ, Swinnerton KN, Bell RK, Landau SM, Jagust WJ. P3-270: Current Cognitive Engagement is Associated with Reduced Glucose Hypometabolism in Cognitively Normal Elderly Alzheimer's & Dementia. 12: P936-P937. DOI: 10.1016/j.jalz.2016.06.1933 |
0.601 |
|
| 2016 |
Arnemann KL, Digma L, Jagust WJ. AMYLOID-β SPREADS FROM MULTIPLE EPICENTERS IN PRECLINICAL ALZHEIMER’S DISEASE Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.1722 |
0.343 |
|
| 2016 |
Arenaza-Urquijo EM, Landau SM, Bell RK, Lockhart SN, Mellinger TJ, Baker SL, Chetelat G, Jagust WJ. IC-P-131: Normal Cognition Despite Very High Risk for Alzheimer’s Disease: Neuroimaging and Neuropsychological Insights Into Resilient Brain Aging Alzheimer's & Dementia. 12: P98-P99. DOI: 10.1016/J.Jalz.2016.06.161 |
0.732 |
|
| 2016 |
Mander BA, Winer JR, Marks S, Vogel JW, Lu BS, Saletin JM, Ancoli-Israel S, Jagust WJ, Walker MP. P2-162: NREM Slow Wave Activity <1HZ as a Biomarker and Long-Term Predictor of B-Amyloid Burden in Older Adults Alzheimer's & Dementia. 12: P676-P677. DOI: 10.1016/J.Jalz.2016.06.1329 |
0.781 |
|
| 2016 |
Schonhaut DR, Ossenkoppele R, Bejanin A, Iaccarino L, Baker SL, Lazaris A, Cantwell A, Tammewar G, Ayakta N, Lockhart S, Scholl M, O'Neil JP, Miller B, Jagust WJ, Rabinovici GD. P1-318: TAU-PET Patterns Overlap and Exceed Hypometabolism in Alzheimer's Disease Alzheimer's & Dementia. 12: P545-P547. DOI: 10.1016/J.Jalz.2016.06.1069 |
0.669 |
|
| 2016 |
Schreiber S, Landau SM, Lockhart S, Bejanin A, Horng A, Schreiber F, Jagust WJ. P1-295: SNAP: Alzheimer's Disease Plus Overlapping Non-Ad Patterns in The Aging Brain? Alzheimer's & Dementia. 12: P533-P534. DOI: 10.1016/J.Jalz.2016.06.1045 |
0.755 |
|
| 2016 |
Snyder N, Chen K, Luo J, Thiyyagura P, Devadas V, Chen Y, Bauer R, Sheline YI, Jagust WJ, Neylan T, Landau SM, Weiner MW, Reiman EM. P1-292: Lower Frontal Amyloid Burden in Antidepressant Users: Preliminary Findings From Persons With and Without Post-Traumatic Stress Disorder in The ADNI DOD Study Alzheimer's & Dementia. 12: P532-P533. DOI: 10.1016/J.Jalz.2016.06.1042 |
0.554 |
|
| 2016 |
Risacher SL, Deters K, Schwarz AJ, Shcherbinin S, West JD, Jagust WJ, Jack CR, Weiner MW, Saykin AJ. Association Of [18F]Av-1451 Tau Markers With Cognitive And Neurodegeneration Measures: Preliminary Analysis In The Adni Cohort Alzheimers & Dementia. 12: 512. DOI: 10.1016/J.Jalz.2016.06.1010 |
0.394 |
|
| 2016 |
Rabinovici GD, Ayakta N, Rosen HJ, Seo SW, O'Neil JP, Janabi M, Ossenkoppele R, Lehmann M, Reed B, Olichney J, Boxer AL, Jin L, Huang E, Gorno-Tempini M, DeCarli C, ... ... Jagust WJ, et al. P1-253: Diagnostic Accuracy of Amyloid- Versus Fdg-Pet in Autopsy-Confirmed Dementia Alzheimer's & Dementia. 12: P506-P507. DOI: 10.1016/J.Jalz.2016.06.1002 |
0.55 |
|
| 2016 |
Ayakta N, Seeley WW, Grinberg LT, Lockhart SN, O'Neil JP, Ossenkoppele R, Reed B, Olichney J, Boxer AL, Miller B, Borys E, Jin L, Huang E, DeCarli C, Jagust WJ, et al. IC-P-055: Centiloid Thresholds for Amyloid Positivity Derived from Autopsy-Proven Cases Alzheimer's & Dementia. 12: P45-P46. DOI: 10.1016/J.Jalz.2016.06.085 |
0.644 |
|
| 2016 |
Horng A, Jagust WJ, Landau SM. IC-P-009: Effects of Baseline Regional Amyloid Deposition Patterns on Subsequent Accumulation Alzheimer's & Dementia. 12: P18-P19. DOI: 10.1016/j.jalz.2016.06.019 |
0.57 |
|
| 2015 |
Lazaris A, Hwang KS, Goukasian N, Ramirez LM, Eastman J, Blanken AE, Teng E, Gylys K, Cole G, Saykin AJ, Shaw LM, Trojanowski JQ, Jagust WJ, Weiner MW, Apostolova LG, et al. Alzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding. Neurology. Genetics. 1: e22. PMID 27066559 DOI: 10.1212/Nxg.0000000000000022 |
0.363 |
|
| 2015 |
Smith CT, Wallace DL, Dang LC, Aarts E, Jagust WJ, D'Esposito M, Boettiger CA. Modulation of Impulsivity and Reward Sensitivity in Intertemporal Choice by Striatal and Midbrain Dopamine Synthesis in Healthy Adults. Journal of Neurophysiology. jn.00261.2015. PMID 26683066 DOI: 10.1152/Jn.00261.2015 |
0.484 |
|
| 2015 |
Tosun D, Schuff N, Jagust W, Weiner MW. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum. Neuro-Degenerative Diseases. PMID 26560336 DOI: 10.1159/000439257 |
0.415 |
|
| 2015 |
Altmann A, Ng B, Landau SM, Jagust WJ, Greicius MD. Regional brain hypometabolism is unrelated to regional amyloid plaque burden. Brain : a Journal of Neurology. PMID 26419799 DOI: 10.1093/Brain/Awv278 |
0.66 |
|
| 2015 |
Schreiber S, Landau SM, Fero A, Schreiber F, Jagust WJ. Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes. Jama Neurology. PMID 26280102 DOI: 10.1001/jamaneurol.2015.1633 |
0.657 |
|
| 2015 |
Ramanan VK, Risacher SL, Nho K, Kim S, Shen L, McDonald BC, Yoder KK, Hutchins GD, West JD, Tallman EF, Gao S, Foroud TM, Farlow MR, De Jager PL, Bennett DA, ... ... Jagust WJ, et al. GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP. Brain : a Journal of Neurology. PMID 26268530 DOI: 10.1093/Brain/Awv231 |
0.484 |
|
| 2015 |
Ossenkoppele R, Cohn-Sheehy BI, La Joie R, Vogel JW, Möller C, Lehmann M, van Berckel BN, Seeley WW, Pijnenburg YA, Gorno-Tempini ML, Kramer JH, Barkhof F, Rosen HJ, van der Flier WM, Jagust WJ, et al. Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease. Human Brain Mapping. PMID 26260856 DOI: 10.1002/Hbm.22927 |
0.77 |
|
| 2015 |
Lehmann M, Madison C, Ghosh PM, Miller ZA, Greicius MD, Kramer JH, Coppola G, Miller BL, Jagust WJ, Gorno-Tempini ML, Seeley WW, Rabinovici GD. Loss of functional connectivity is greater outside the default mode network in nonfamilial early-onset Alzheimer's disease variants. Neurobiology of Aging. 36: 2678-86. PMID 26242705 DOI: 10.1016/J.Neurobiolaging.2015.06.029 |
0.368 |
|
| 2015 |
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, et al. Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 865-84. PMID 26194320 DOI: 10.1016/J.Jalz.2015.04.005 |
0.513 |
|
| 2015 |
Jagust WJ, Landau SM, Koeppe RA, Reiman EM, Chen K, Mathis CA, Price JC, Foster NL, Wang AY. The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 757-71. PMID 26194311 DOI: 10.1016/J.Jalz.2015.05.001 |
0.644 |
|
| 2015 |
Ossenkoppele R, Pijnenburg YA, Perry DC, Cohn-Sheehy BI, Scheltens NM, Vogel JW, Kramer JH, van der Vlies AE, Joie RL, Rosen HJ, van der Flier WM, Grinberg LT, Rozemuller AJ, Huang EJ, van Berckel BN, ... ... Jagust WJ, et al. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features. Brain : a Journal of Neurology. 138: 2732-49. PMID 26141491 DOI: 10.1093/Brain/Awv191 |
0.774 |
|
| 2015 |
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Green RC, Harvey D, Jack CR, Jagust W, Luthman J, Morris JC, Petersen RC, Saykin AJ, Shaw L, et al. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: e1-e120. PMID 26073027 DOI: 10.1016/J.Jalz.2014.11.001 |
0.489 |
|
| 2015 |
Naasan G, Rabinovici GD, Ghosh P, Elofson JD, Miller BL, Coppola G, Karydas A, Fong J, Perry D, Lee SE, Yokoyama JS, Seeley WW, Kramer JH, Weiner MW, Schuff N, ... Jagust WJ, et al. Amyloid in dementia associated with familial FTLD: not an innocent bystander. Neurocase. 1-8. PMID 26040468 DOI: 10.1080/13554794.2015.1046458 |
0.462 |
|
| 2015 |
Mander BA, Marks SM, Vogel JW, Rao V, Lu B, Saletin JM, Ancoli-Israel S, Jagust WJ, Walker MP. β-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation. Nature Neuroscience. 18: 1051-7. PMID 26030850 DOI: 10.1038/Nn.4035 |
0.811 |
|
| 2015 |
Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ, Verfaillie SC, Zwan MD, Adriaanse SM, Lammertsma AA, Barkhof F, Jagust WJ, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. Jama. 313: 1939-49. PMID 25988463 DOI: 10.1001/Jama.2015.4669 |
0.728 |
|
| 2015 |
Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, ... ... Jagust WJ, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. Jama. 313: 1924-38. PMID 25988462 DOI: 10.1001/Jama.2015.4668 |
0.688 |
|
| 2015 |
Wallace DL, Aarts E, d'Oleire Uquillas F, Dang LC, Greer SM, Jagust WJ, D'Esposito M. Genotype status of the dopamine-related catechol-O-methyltransferase (COMT) gene corresponds with desirability of "unhealthy" foods. Appetite. 92: 74-80. PMID 25963102 DOI: 10.1016/J.Appet.2015.05.004 |
0.438 |
|
| 2015 |
Risacher SL, Kim S, Nho K, Foroud T, Shen L, Petersen RC, Jack CR, Beckett LA, Aisen PS, Koeppe RA, Jagust WJ, Shaw LM, Trojanowski JQ, Weiner MW, Saykin AJ, et al. APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25960448 DOI: 10.1016/J.Jalz.2015.03.003 |
0.437 |
|
| 2015 |
Villeneuve S, Rabinovici GD, Cohn-Sheehy BI, Madison C, Ayakta N, Ghosh PM, La Joie R, Arthur-Bentil SK, Vogel JW, Marks SM, Lehmann M, Rosen HJ, Reed B, Olichney J, Boxer AL, ... ... Jagust W, et al. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain : a Journal of Neurology. 138: 2020-33. PMID 25953778 DOI: 10.1093/Brain/Awv112 |
0.81 |
|
| 2015 |
Boutchko R, Mitra D, Baker SL, Jagust WJ, Gullberg GT. Clustering-initiated factor analysis application for tissue classification in dynamic brain positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 35: 1104-11. PMID 25899294 DOI: 10.1038/Jcbfm.2015.69 |
0.305 |
|
| 2015 |
Villeneuve S, Jagust WJ. Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment. The Journal of Prevention of Alzheimer's Disease. 2: 64-70. PMID 25844350 DOI: 10.14283/jpad.2015.47 |
0.552 |
|
| 2015 |
Toledo JB, Bjerke M, Da X, Landau SM, Foster NL, Jagust W, Jack C, Weiner M, Davatzikos C, Shaw LM, Trojanowski JQ. Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease. Jama Neurology. 72: 571-81. PMID 25822737 DOI: 10.1001/Jamaneurol.2014.4829 |
0.66 |
|
| 2015 |
Mattsson N, Insel PS, Donohue M, Jagust W, Sperling R, Aisen P, Weiner MW. Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls. Jama Neurology. 72: 554-60. PMID 25775167 DOI: 10.1001/Jamaneurol.2014.4530 |
0.421 |
|
| 2015 |
Landau SM, Fero A, Baker SL, Koeppe R, Mintun M, Chen K, Reiman EM, Jagust WJ. Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 567-74. PMID 25745095 DOI: 10.2967/Jnumed.114.148981 |
0.646 |
|
| 2015 |
Chen K, Roontiva A, Thiyyagura P, Lee W, Liu X, Ayutyanont N, Protas H, Luo JL, Bauer R, Reschke C, Bandy D, Koeppe RA, Fleisher AS, Caselli RJ, Landau S, ... Jagust WJ, et al. Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 560-6. PMID 25745091 DOI: 10.2967/Jnumed.114.149732 |
0.616 |
|
| 2015 |
Sha SJ, Ghosh PM, Lee SE, Corbetta-Rastelli C, Jagust WJ, Kornak J, Rankin KP, Grinberg LT, Vinters HV, Mendez MF, Dickson DW, Seeley WW, Gorno-Tempini M, Kramer J, Miller BL, et al. Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. Alzheimer's Research & Therapy. 7: 8. PMID 25733984 DOI: 10.1186/S13195-014-0093-Y |
0.331 |
|
| 2015 |
Apostolova LG, Hwang KS, Avila D, Elashoff D, Kohannim O, Teng E, Sokolow S, Jack CR, Jagust WJ, Shaw L, Trojanowski JQ, Weiner MW, Thompson PM. Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures. Neurology. 84: 729-37. PMID 25609767 DOI: 10.1212/Wnl.0000000000001231 |
0.513 |
|
| 2015 |
Mattsson N, Insel PS, Donohue M, Landau S, Jagust WJ, Shaw LM, Trojanowski JQ, Zetterberg H, Blennow K, Weiner MW. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease. Brain : a Journal of Neurology. 138: 772-83. PMID 25541191 DOI: 10.1093/Brain/Awu367 |
0.678 |
|
| 2015 |
Dowling NM, Johnson SC, Gleason CE, Jagust WJ. The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function. Neuroimage. 105: 357-68. PMID 25450107 DOI: 10.1016/j.neuroimage.2014.10.050 |
0.507 |
|
| 2015 |
Ossenkoppele R, Schonhaut DR, Baker SL, O'Neil JP, Janabi M, Ghosh PM, Santos M, Miller ZA, Bettcher BM, Gorno-Tempini ML, Miller BL, Jagust WJ, Rabinovici GD. Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy. Annals of Neurology. 77: 338-42. PMID 25448043 DOI: 10.1002/Ana.24321 |
0.45 |
|
| 2015 |
Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Jagust WJ, Johnson KA, Mathis CA, Minhas D, Pontecorvo MJ, Rowe CC, Skovronsky DM, Mintun MA. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 1-15.e1-4. PMID 25443857 DOI: 10.1016/J.Jalz.2014.07.003 |
0.363 |
|
| 2015 |
Caroli A, Prestia A, Wade S, Chen K, Ayutyanont N, Landau SM, Madison CM, Haense C, Herholz K, Reiman EM, Jagust WJ, Frisoni GB. Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI. Alzheimer Disease and Associated Disorders. 29: 101-9. PMID 25437302 DOI: 10.1097/WAD.0000000000000071 |
0.602 |
|
| 2015 |
Vogel JW, Doležalová MV, Joie RL, Marks S, Fero A, Landau SM, Schwimmer H, Schreiber S, Jagust WJ. Brain and cognitive correlates of subjective cognitive decline differ between healthy elderly with and without β-amyloid pathology Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.451 |
0.64 |
|
| 2015 |
Schöll M, Vogel JW, Schonhaut D, Lockhart S, Baker S, Schwimmer H, Ossenkoppele R, Rabinovici GD, Jagust WJ. Cognitive decline in healthy elderly is related to temporal lobe tau but not to cortical β-amyloid: An 18F-AV1451 and 11C-PiB PET study Alzheimers & Dementia. 11: 313-314. DOI: 10.1016/J.Jalz.2015.07.448 |
0.683 |
|
| 2015 |
Seo SW, Ayakta N, Lehmann M, Miller BL, Grinberg LT, Seeley WW, Jagust WJ, Rabinovici GD. O4-08-01: Regional correlations between PiB-PET and postmortem burden of amyloid species Alzheimer's & Dementia. 11: P285-P286. DOI: 10.1016/J.Jalz.2015.07.387 |
0.338 |
|
| 2015 |
Ramanan VK, Risacher SL, Nho K, Kim S, Shen L, Foroud TM, Aisen PS, Petersen RC, Toga AW, Green RC, Jagust WJ, Weiner MW, Saykin AJ. Gwas of longitudinal amyloid PET identifies IL1RAP as a new potential Alzheimer's disease target Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.369 |
0.426 |
|
| 2015 |
Ossenkoppele R, Pijnenburg YA, Perry D, Cohn-Sheehy B, Scheltens NM, Vogel JW, Kramer J, van der Vlies A, La Joie R, Rosen H, van der Flier WM, Grinberg L, Rozemuller A, Huang E, van Berckel BN, ... ... Jagust WJ, et al. F2-03-03: Characterization of the behavioral and dysexecutive variants of Alzheimer's disease Alzheimer's & Dementia. 11: P168-P168. DOI: 10.1016/J.Jalz.2015.07.118 |
0.744 |
|
| 2015 |
Rabinovici GD, Schonhaut D, Baker S, Lazaris A, Ayakta N, Cantwell A, Lockhart S, Vogel JW, Schwimmer H, Schöll M, Gorno Tempini ML, Miller BL, Jagust WJ, Ossenkoppele R. F2-03-01: Tau and amyloid neuroimaging of ad phenotypes Alzheimer's & Dementia. 11: P167-P167. DOI: 10.1016/J.Jalz.2015.07.116 |
0.661 |
|
| 2015 |
Walker MP, Mander BA, Marks S, Rao V, Lu BS, Saletin J, Ancoli-Israel S, Jagust WJ. F2-02-03: Beta-amyloid deposition in the human brain disrupts nrem slow wave sleep and associated hippocampus-dependent long-term memory Alzheimer's & Dementia. 11: P166-P166. DOI: 10.1016/J.Jalz.2015.07.114 |
0.789 |
|
| 2015 |
Lockhart S, Schöll M, Schonhaut D, Ossenkoppele R, Vogel JW, Baker S, Schwimmer H, Rabinovici GD, Jagust WJ. Examining relations of age and beta-amyloid with tau deposition measured using 18F-AV-1451 in cognitively normal older adults Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.191 |
0.666 |
|
| 2015 |
Rabinovici GD, Schonhaut D, Baker S, Lazaris A, Ossenkoppele R, Lockhart S, Schöll M, Schwimmer H, Vogel JW, Ayakta N, Rosen H, Miller BL, O'Neil JP, Boxer AL, Jagust WJ. IC-P-161: Tau PET with [18
F]AV1451 in non-alzheimer's disease neurodegenerative syndromes Alzheimer's & Dementia. 11: P107-P109. DOI: 10.1016/J.Jalz.2015.06.184 |
0.652 |
|
| 2015 |
Schonhaut D, Ossenkoppele R, Schöll M, Lockhart S, Baker S, Lazaris A, Cantwell A, Vogel JW, Ayakta N, Gorno-Tempini M, Miller ZA, O'Neil JP, Miller BL, Jagust WJ, Rabinovici GD. IC-P-157: Associations of [18
F]AV1451 Tau PET with age, ApoE genotype, and cognition in Alzheimer's disease Alzheimer's & Dementia. 11: P105-P106. DOI: 10.1016/J.Jalz.2015.06.180 |
0.691 |
|
| 2015 |
Vogel JW, Hishinuma AK, Marks S, Joie RL, Schwimmer H, Jagust WJ. Longitudinal gray matter changes in cognitively intact individuals with and without brain β-amyloid pathology Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.167 |
0.398 |
|
| 2015 |
Villeneuve S, St. Amant H, Vogel JW, Marks S, Wirth M, DeCarli C, Jagust WJ. P3-145: Are low levels of PiB-PET signal clinically significant? Alzheimer's & Dementia. 11: P681-P682. DOI: 10.1016/J.Jalz.2015.06.1013 |
0.62 |
|
| 2015 |
Landau SM, Fero A, Jagust WJ. IC-P-058: Amyloid negativity in clinically diagnosed ADNI Alzheimer's disease and MCI patients Alzheimer's & Dementia. 11: P44-P44. DOI: 10.1016/j.jalz.2015.06.079 |
0.627 |
|
| 2015 |
Nho K, Kim S, Risacher SL, Foroud TM, Aisen PS, Petersen RC, Jagust WJ, Jack CR, Shaw LM, Trojanowski JQ, Weiner MW, Green RC, Toga AW, Greicius MD, Saykin AJ. IC-P-042: Influence of rare reelin variants on quantitative PET imaging and CSF phenotypes in late-onset Alzheimer's disease Alzheimer's & Dementia. 11: P36-P36. DOI: 10.1016/J.Jalz.2015.06.062 |
0.382 |
|
| 2015 |
Risacher SL, Kim S, Nho K, Jack CR, Jagust WJ, Aisen PS, Petersen RC, Weiner MW, Saykin AJ. Association of cerebral microhemorrhages with amyloid deposition and hyperlipidemia Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.057 |
0.334 |
|
| 2015 |
Ossenkoppele R, Schonhaut D, Baker S, Lazaris A, Ayakta N, Cantwell A, Lockhart S, Vogel JW, Schwimmer H, Schöll M, Gorno Tempini ML, Miller BL, Jagust WJ, Rabinovici GD. IC-02-02: Distinct [18
F]AV1451 retention patterns in clinical variants of Alzheimer's disease Alzheimer's & Dementia. 11: P5-P6. DOI: 10.1016/J.Jalz.2015.06.008 |
0.622 |
|
| 2015 |
Schöll M, Schonhaut D, Lockhart S, Vogel JW, Baker S, Schwimmer H, Ossenkoppele R, Rabinovici GD, Jagust WJ. In vivo braak staging using 18F-AV1451 Tau PET imaging Alzheimers & Dementia. 11: 4. DOI: 10.1016/J.Jalz.2015.06.006 |
0.612 |
|
| 2015 |
Villeneuve S, Amant HS, Vogel JW, Marks S, Wirth M, DeCarli C, Jagust WJ. IC-01-01: Are low levels of PiB-PET signal clinically significant? Alzheimer's & Dementia. 11: P1-P1. DOI: 10.1016/J.Jalz.2015.06.002 |
0.611 |
|
| 2015 |
Jagust WJ, Landau SM, Koeppe RA, Reiman EM, Chen K, Mathis CA, Price JC, Foster NL, Wang AY. The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015 Alzheimer's and Dementia. 11: 757-771. DOI: 10.1016/j.jalz.2015.05.001 |
0.602 |
|
| 2014 |
Schicktanz S, Schweda M, Ballenger JF, Fox PJ, Halpern J, Kramer JH, Micco G, Post SG, Thompson C, Knight RT, Jagust WJ. Before it is too late: professional responsibilities in late-onset Alzheimer's research and pre-symptomatic prediction. Frontiers in Human Neuroscience. 8: 921. PMID 25477802 DOI: 10.3389/Fnhum.2014.00921 |
0.349 |
|
| 2014 |
Schmidt ME, Chiao P, Klein G, Matthews D, Thurfjell L, Cole PE, Margolin R, Landau S, Foster NL, Mason NS, De Santi S, Suhy J, Koeppe RA, Jagust W. The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25457431 DOI: 10.1016/J.Jalz.2014.09.004 |
0.631 |
|
| 2014 |
Elman JA, Madison CM, Baker SL, Vogel JW, Marks SM, Crowley S, O'Neil JP, Jagust WJ. Effects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional Vulnerability. Cerebral Cortex (New York, N.Y. : 1991). PMID 25405944 DOI: 10.1093/Cercor/Bhu259 |
0.707 |
|
| 2014 |
Mattsson N, Insel PS, Landau S, Jagust W, Donohue M, Shaw LM, Trojanowski JQ, Zetterberg H, Blennow K, Weiner M. Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease. Annals of Clinical and Translational Neurology. 1: 534-43. PMID 25356425 DOI: 10.1002/Acn3.81 |
0.665 |
|
| 2014 |
Elman JA, Oh H, Madison CM, Baker SL, Vogel JW, Marks SM, Crowley S, O'Neil JP, Jagust WJ. Neural compensation in older people with brain amyloid-β deposition. Nature Neuroscience. 17: 1316-8. PMID 25217827 DOI: 10.1038/Nn.3806 |
0.81 |
|
| 2014 |
Wirth M, Villeneuve S, La Joie R, Marks SM, Jagust WJ. Gene-environment interactions: lifetime cognitive activity, APOE genotype, and β-amyloid burden. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8612-7. PMID 24948815 DOI: 10.1523/Jneurosci.4612-13.2014 |
0.658 |
|
| 2014 |
Weiner MW, Veitch DP, Hayes J, Neylan T, Grafman J, Aisen PS, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Shaw LM, Saykin AJ, Green RC, Harvey D, Toga AW, et al. Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: S226-35. PMID 24924673 DOI: 10.1016/J.Jalz.2014.04.005 |
0.418 |
|
| 2014 |
Villeneuve S, Reed BR, Madison CM, Wirth M, Marchant NL, Kriger S, Mack WJ, Sanossian N, DeCarli C, Chui HC, Weiner MW, Jagust WJ. Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions. Neurology. 83: 40-7. PMID 24907234 DOI: 10.1212/Wnl.0000000000000550 |
0.785 |
|
| 2014 |
Laforce R, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology. Neuroimage. Clinical. 4: 508-16. PMID 24818077 DOI: 10.1016/J.Nicl.2014.03.005 |
0.469 |
|
| 2014 |
Wallace DL, Aarts E, Dang LC, Greer SM, Jagust WJ, D'Esposito M. Dorsal striatal dopamine, food preference and health perception in humans. Plos One. 9: e96319. PMID 24806534 DOI: 10.1371/Journal.Pone.0096319 |
0.452 |
|
| 2014 |
Jagust W. Time for tau Brain. 137: 1570-1571. PMID 24736306 DOI: 10.1093/brain/awu093 |
0.421 |
|
| 2014 |
Wirth M, Haase CM, Villeneuve S, Vogel J, Jagust WJ. Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults. Neurobiology of Aging. 35: 1873-82. PMID 24656834 DOI: 10.1016/J.Neurobiolaging.2014.02.015 |
0.658 |
|
| 2014 |
Landau SM, Thomas BA, Thurfjell L, Schmidt M, Margolin R, Mintun M, Pontecorvo M, Baker SL, Jagust WJ. Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers. European Journal of Nuclear Medicine and Molecular Imaging. 41: 1398-407. PMID 24647577 DOI: 10.1007/S00259-014-2753-3 |
0.653 |
|
| 2014 |
Mattsson N, Tosun D, Insel PS, Simonson A, Jack CR, Beckett LA, Donohue M, Jagust W, Schuff N, Weiner MW. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. Brain : a Journal of Neurology. 137: 1550-61. PMID 24625697 DOI: 10.1093/Brain/Awu043 |
0.422 |
|
| 2014 |
Toledo JB, Weiner MW, Wolk DA, Da X, Chen K, Arnold SE, Jagust W, Jack C, Reiman EM, Davatzikos C, Shaw LM, Trojanowski JQ. Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition. Acta Neuropathologica Communications. 2: 26. PMID 24602322 DOI: 10.1186/2051-5960-2-26 |
0.451 |
|
| 2014 |
Aarts E, Wallace DL, Dang LC, Jagust WJ, Cools R, D'Esposito M. Dopamine and the cognitive downside of a promised bonus. Psychological Science. 25: 1003-9. PMID 24525265 DOI: 10.1177/0956797613517240 |
0.517 |
|
| 2014 |
Lee JY, Park S, Mackin S, Ewers M, Chui H, Jagust W, Insel PS, Weiner MW. Differences in prefrontal, limbic, and white matter lesion volumes according to cognitive status in elderly patients with first-onset subsyndromal depression. Plos One. 9: e87747. PMID 24498184 DOI: 10.1371/Journal.Pone.0087747 |
0.394 |
|
| 2014 |
Villeneuve S, Reed BR, Wirth M, Haase CM, Madison CM, Ayakta N, Mack W, Mungas D, Chui HC, DeCarli C, Weiner MW, Jagust WJ. Cortical thickness mediates the effect of β-amyloid on episodic memory. Neurology. 82: 761-7. PMID 24489134 DOI: 10.1212/Wnl.0000000000000170 |
0.67 |
|
| 2014 |
Reed B, Villeneuve S, Mack W, DeCarli C, Chui HC, Jagust W. Associations between serum cholesterol levels and cerebral amyloidosis. Jama Neurology. 71: 195-200. PMID 24378418 DOI: 10.1001/Jamaneurol.2013.5390 |
0.654 |
|
| 2014 |
Sánchez-Juan P, Ghosh PM, Hagen J, Gesierich B, Henry M, Grinberg LT, O'Neil JP, Janabi M, Huang EJ, Trojanowski JQ, Vinters HV, Gorno-Tempini M, Seeley WW, Boxer AL, Rosen HJ, ... ... Jagust WJ, et al. Practical utility of amyloid and FDG-PET in an academic dementia center. Neurology. 82: 230-8. PMID 24353340 DOI: 10.1212/Wnl.0000000000000032 |
0.402 |
|
| 2014 |
Lehmann M, Ghosh PM, Madison C, Karydas A, Coppola G, O'Neil JP, Huang Y, Miller BL, Jagust WJ, Rabinovici GD. Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 266-73. PMID 23965289 DOI: 10.1136/Jnnp-2013-305858 |
0.444 |
|
| 2014 |
Mander BA, Rao V, Lu B, Saletin JM, Ancoli-Israel S, Jagust WJ, Walker MP. Impaired prefrontal sleep spindle regulation of hippocampal-dependent learning in older adults. Cerebral Cortex (New York, N.Y. : 1991). 24: 3301-9. PMID 23901074 DOI: 10.1093/Cercor/Bht188 |
0.787 |
|
| 2014 |
Swaminathan S, Risacher SL, Yoder KK, West JD, Shen L, Kim S, Inlow M, Foroud T, Jagust WJ, Koeppe RA, Mathis CA, Shaw LM, Trojanowski JQ, Soares H, Aisen PS, et al. Association of plasma and cortical amyloid beta is modulated by APOE ε4 status. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: e9-e18. PMID 23541187 DOI: 10.1016/J.Jalz.2013.01.007 |
0.34 |
|
| 2014 |
Ossenkoppele R, Madison C, Oh H, Wirth M, van Berckel BN, Jagust WJ. Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function? Cerebral Cortex (New York, N.Y. : 1991). 24: 2210-8. PMID 23537530 DOI: 10.1093/Cercor/Bht076 |
0.761 |
|
| 2014 |
Ramanan VK, Risacher SL, Nho K, Kim S, Swaminathan S, Shen L, Foroud TM, Hakonarson H, Huentelman MJ, Aisen PS, Petersen RC, Green RC, Jack CR, Koeppe RA, Jagust WJ, et al. APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study. Molecular Psychiatry. 19: 351-7. PMID 23419831 DOI: 10.1038/Mp.2013.19 |
0.428 |
|
| 2014 |
Oh H, Madison C, Villeneuve S, Markley C, Jagust WJ. Association of gray matter atrophy with age, β-amyloid, and cognition in aging. Cerebral Cortex (New York, N.Y. : 1991). 24: 1609-18. PMID 23389995 DOI: 10.1093/Cercor/Bht017 |
0.811 |
|
| 2014 |
Oh H, Habeck C, Madison C, Jagust W. Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly. Human Brain Mapping. 35: 297-308. PMID 22965806 DOI: 10.1002/Hbm.22173 |
0.768 |
|
| 2014 |
Chen K, Roontiva A, Thiyyagura P, Lee W, Liu X, Ayutyanont N, Protas H, Landau S, Luo J, Bauer R, Reschke C, Bandy D, Koeppe R, Fleisher AS, Caselli RJ, ... Jagust W, et al. Improving The Power To Track Fibrillar Amyloid Pet Measurements And Evaluate Amyloid-Modifying Treatments Using A Cerebral White Matter Reference Region-Of-Interest Alzheimers & Dementia. 10: 894. DOI: 10.1016/J.Jalz.2014.07.069 |
0.544 |
|
| 2014 |
Mattsson N, Insel P, Landau S, Jagust W, Shaw L, Trojanowski JQ, Zetterberg H, Blennow K, Weiner MW. P2-094: COMPARING THE DIAGNOSTIC ACCURACIES OF CSF Aβ42 AND PET FLORBETAPIR Alzheimer's & Dementia. 10: P505-P505. DOI: 10.1016/J.Jalz.2014.05.768 |
0.614 |
|
| 2014 |
Ramanan VK, Nho K, Risacher SL, Kim S, Shen L, Swaminathan S, Foroud TM, Aisen P, Hakonarson H, Huentelman M, Jack C, Jagust W, Petersen RC, Potkin S, Shaw L, et al. P3-024: NEXT-GENERATION SEQUENCING OF THE BCHE LOCUS IDENTIFIES A FUNCTIONAL SNP ASSOCIATED WITH ALZHEIMER'S DISEASE BIOMARKERS AND AGE OF ONSET Alzheimer's & Dementia. 10: P636-P636. DOI: 10.1016/J.Jalz.2014.05.1111 |
0.408 |
|
| 2014 |
Risacher SL, Kim S, Nho KT, West JD, Wang Y, Petersen RC, Aisen PS, Jack CR, Jagust WJ, Koeppe R, Weiner MW, Saykin AJ. IC-P-096: INCREASED AMYLOID DEPOSITION IN OLDER ADULTS AT RISK FOR PROGRESSION TO ALZHEIMER'S DISEASE DUE TO GENETIC BACKGROUND AND/OR THE PRESENCE OF SIGNIFICANT MEMORY CONCERNS Alzheimer's & Dementia. 10: P54-P54. DOI: 10.1016/J.Jalz.2014.05.101 |
0.397 |
|
| 2014 |
Ghosh PM, Madison C, Santos M, Norton K, Baker S, Boxer AL, Rosen HJ, Miller ZA, Gorno-Tempini M, Miller BL, Jagust W, Rabinovici GD. IC-P-023: AMYLOID PET HAS GREATER CLINICAL IMPACT THAN FDG PET IN THE DIFFERENTIAL DIAGNOSIS OF AD AND FTD Alzheimer's & Dementia. 10: P17-P18. DOI: 10.1016/J.Jalz.2014.05.027 |
0.396 |
|
| 2014 |
Rabinovici GD, Cohn-Sheehy BI, Reed B, Villeneuve S, Ghosh PM, Madison C, Lehmann M, Olichney J, DeCarli CS, Miller BL, Borys E, Grinberg LT, Jin L, Seeley WW, Jagust WJ. IC-P-011: COMPARING LIBERAL AND CONSERVATIVE THRESHOLDS FOR AMYLOID PET POSITIVITY IN AUTOPSY-PROVEN CASES Alzheimer's & Dementia. 10: P12-P13. DOI: 10.1016/J.Jalz.2014.05.015 |
0.782 |
|
| 2014 |
Rabinovici GD, Ossenkoppele R, Perrotin A, Dore V, Jagust W, Bouwman FH, La Joie R, Villemagne VL, Miller B, Van der Flier WM, de La Sayette V, Masters CL, Scheltens P, van Berckel B, Rowe CC, et al. IC-P-010: CLINICALLY DIAGNOSED PROBABLE AD CASES WITH A NEGATIVE AMYLOID PET SCAN: CLINICAL FINDINGS Alzheimer's & Dementia. 10: P12-P12. DOI: 10.1016/J.Jalz.2014.05.014 |
0.381 |
|
| 2014 |
Chetelat G, Villemagne VL, Jagust W, Ossenkoppele R, Perrotin A, Dore V, Miller B, Flier WMvd, Joie RL, Ames D, Berckel Bv, Landeau B, Scheltens P, Mézenge F, Rowe CC, et al. Neurodegenerative And Cognitive Profile Of Patients With A Typical Phenotype Of Ad But With A Negative Amyloid Scan Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.013 |
0.459 |
|
| 2014 |
Lehmann M, Cohn-Sheehy BI, Pijnenburg Y, Seeley W, van Berckel B, Miller B, Lehmann M, Gorno-Tempini M, Kramer JH, van der Flier WM, Rosen H, Scheltens P, Jagust W, Barkhof F, Rabinovici GD. O5-01-05: COMPARING ATROPHY PATTERNS IN EARLY CLINICAL STAGES ACROSS DISTINCT PHENOTYPES OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P289-P289. DOI: 10.1016/J.Jalz.2014.04.480 |
0.734 |
|
| 2014 |
Joie RL, Crowley S, Marks S, Vogel J, Wendelken C, Bunge S, Jagust W. Spatial Correlation Between Gray Matter Changes In Childhood, Fdg Metabolism In Young Adults, And Beta-Amyloid Deposition In The Elderly Alzheimers & Dementia. 10: 229. DOI: 10.1016/J.Jalz.2014.04.327 |
0.346 |
|
| 2014 |
Wirth M, Villeneuve S, La Joie R, Marks SM, Jagust WJ. O3-10-02: LIFETIME COGNITIVE ACTIVITY, APOLIPOPROTEIN E GENOTYPE, AND BRAIN BETA-AMYLOID Alzheimer's & Dementia. 10: P228-P228. DOI: 10.1016/J.Jalz.2014.04.324 |
0.587 |
|
| 2014 |
Risacher SL, Kim S, Nho KT, West JD, Petersen RC, Aisen PS, Jack CR, Jagust WJ, Koeppe R, Weiner MW, Saykin AJ. O3-03-02: TWO-YEAR LONGITUDINAL CHANGE IN AMYLOID DEPOSITION, GLUCOSE METABOLISM, AND HIPPOCAMPAL ATROPHY IN ADNI-2 PARTICIPANTS: RELATION TO GENETIC RISK Alzheimer's & Dementia. 10: P211-P212. DOI: 10.1016/J.Jalz.2014.04.281 |
0.302 |
|
| 2014 |
Mattsson N, Insel P, Landau S, Jagust W, Shaw L, Trojanowski JQ, Zetterberg H, Blennow K, Weiner MW. O2-05-06: COMBINING CSF AB42 AND PET FLORBETAPIR TO PREDICT DIAGNOSIS, TAU, ATROPHY, AND COGNITION Alzheimer's & Dementia. 10: P174-P174. DOI: 10.1016/J.Jalz.2014.04.185 |
0.622 |
|
| 2014 |
Nosheny RL, Insel P, Mattsson N, Tosun D, Truran D, Schuff N, Jagust W, Petersen RC, Jack C, Aisen P, Weiner M. O1-07-03: EFFECTS OF AMYLOID STATUS AND AGE ON LONGITUDINAL REGIONAL BRAIN ATROPHY IN ELDERLY HEALTHY CONTROLS Alzheimer's & Dementia. 10: P142-P143. DOI: 10.1016/J.Jalz.2014.04.094 |
0.34 |
|
| 2014 |
Landau S, Fero A, Baker S, Jagust W. Modeling Longitudinal Florbetapir Change Across The Disease Spectrum Alzheimers & Dementia. 10: 7. DOI: 10.1016/J.Jalz.2014.04.031 |
0.542 |
|
| 2014 |
Villeneuve S, Madison C, Ayakta N, La Joie R, Cohn-Sheehy BI, Vogel J, Marks S, Arthur-Bentil SK, Reed B, DeCarli C, Rabinovici GD, Jagust W. IC-02-03: EXISTING THRESHOLDS FOR PIB POSITIVITY ARE TOO HIGH Alzheimer's & Dementia. 10: P4-P5. DOI: 10.1016/J.Jalz.2014.04.026 |
0.756 |
|
| 2014 |
DeCarli C, Mungas D, Carmichael OT, Villeneuve S, Fletcher E, Singh B, Jagust W, Reed B. IC-01-04: VASCULAR RISK FACTORS IMPACT COGNITION INDEPENDENT OF PIB PET AND MRI MEASURES OF AD AND VASCULAR BRAIN INJURY Alzheimer's & Dementia. 10: P2-P3. DOI: 10.1016/J.Jalz.2014.04.021 |
0.673 |
|
| 2013 |
DeLuca AN, Heflin L, Fang S, Melisko ME, Moasser MM, Park JW, Chien AJ, Munster PN, Esserman L, Landau SM, Jagust WJ, Kramer JH. Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (ESBC): Predictors of cognitive decline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 104. PMID 28136629 DOI: 10.1200/Jco.2013.31.26_Suppl.104 |
0.588 |
|
| 2013 |
Fang S, DeLuca AN, Melisko ME, Moasser MM, Park JW, Chien AJ, Munster PN, Landau SM, Jagust WJ, Kramer JH, Rugo HS. Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (BC): Relationship between perceived and measurable cognitive deficits. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 105. PMID 28136615 DOI: 10.1200/Jco.2013.31.15_Suppl.6619 |
0.589 |
|
| 2013 |
He BJ, Nolte G, Nagata K, Takano D, Yamazaki T, Fujimaki Y, Maeda T, Satoh Y, Heckers S, George MS, Lopes da Silva F, de Munck JC, Van Houdt PJ, Verdaasdonk RM, Ossenblok P, ... ... Jagust WJ, et al. Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), the International Society for Functional Source Imaging (ISFSI), the International Society for Bioelectromagnetism (ISBEM), the International Society for Brain Electromagnetic Topography (ISBET), and the EEG and Clinical Neuroscience Society (ECNS), in Geneva, Switzerland, September 5-8, 2013. Clinical Eeg and Neuroscience. PMID 24368763 DOI: 10.1177/1550059413507209 |
0.514 |
|
| 2013 |
Oh H, Jagust WJ. Frontotemporal network connectivity during memory encoding is increased with aging and disrupted by beta-amyloid. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 18425-37. PMID 24259567 DOI: 10.1523/Jneurosci.2775-13.2013 |
0.734 |
|
| 2013 |
Wirth M, Villeneuve S, Haase CM, Madison CM, Oh H, Landau SM, Rabinovici GD, Jagust WJ. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people. Jama Neurology. 70: 1512-9. PMID 24166579 DOI: 10.1001/Jamaneurol.2013.4013 |
0.852 |
|
| 2013 |
Jagust W. Biomarkers and brain connectivity Jama Neurology. 70: 1233-1234. PMID 23959142 DOI: 10.1001/jamaneurol.2013.3743 |
0.519 |
|
| 2013 |
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, et al. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: e111-94. PMID 23932184 DOI: 10.1016/j.jalz.2013.05.1769 |
0.385 |
|
| 2013 |
Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, Reiman EM, Scheltens P, Barkhof F, Black SE, Brooks DJ, Carrillo MC, Fox NC, Herholz K, Nordberg A, ... ... Jagust WJ, et al. Imaging markers for Alzheimer disease: which vs how. Neurology. 81: 487-500. PMID 23897875 DOI: 10.1212/Wnl.0B013E31829D86E8 |
0.633 |
|
| 2013 |
Lehmann M, Madison CM, Ghosh PM, Seeley WW, Mormino E, Greicius MD, Gorno-Tempini ML, Kramer JH, Miller BL, Jagust WJ, Rabinovici GD. Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 110: 11606-11. PMID 23798398 DOI: 10.1073/Pnas.1221536110 |
0.599 |
|
| 2013 |
Haight TJ, Landau SM, Carmichael O, Schwarz C, DeCarli C, Jagust WJ. Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism. Jama Neurology. 70: 1039-45. PMID 23779022 DOI: 10.1001/Jamaneurol.2013.1878 |
0.716 |
|
| 2013 |
Chao LL, Decarli C, Kriger S, Truran D, Zhang Y, Laxamana J, Villeneuve S, Jagust WJ, Sanossian N, Mack WJ, Chui HC, Weiner MW. Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI. Plos One. 8: e65175. PMID 23762308 DOI: 10.1371/Journal.Pone.0065175 |
0.671 |
|
| 2013 |
Landau S, Jagust W. Physical Activity and AD-Related Pathology-Reply. Archives of Neurology. 69: 940-1. PMID 23753644 DOI: 10.1001/archneurol.2012.510 |
0.557 |
|
| 2013 |
Landau S, Jagust W. Physical Activity and AD-Related Pathology-Reply. Archives of Neurology. 69: 940-1. PMID 23753644 DOI: 10.1001/archneurol.2012.510 |
0.557 |
|
| 2013 |
Wu X, Li J, Ayutyanont N, Protas H, Jagust W, Fleisher A, Reiman E, Yao L, Chen K. The receiver operational characteristic for binary classification with multiple indices and its application to the neuroimaging study of Alzheimer's disease. Ieee/Acm Transactions On Computational Biology and Bioinformatics / Ieee, Acm. 10: 173-80. PMID 23702553 DOI: 10.1109/Tcbb.2012.141 |
0.339 |
|
| 2013 |
Risacher SL, Kim S, Shen L, Nho K, Foroud T, Green RC, Petersen RC, Jack CR, Aisen PS, Koeppe RA, Jagust WJ, Shaw LM, Trojanowski JQ, Weiner MW, Saykin AJ, et al. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Frontiers in Aging Neuroscience. 5: 11. PMID 23554593 DOI: 10.3389/Fnagi.2013.00011 |
0.466 |
|
| 2013 |
Lo RY, Jagust WJ. Effect of cognitive reserve markers on Alzheimer pathologic progression. Alzheimer Disease and Associated Disorders. 27: 343-50. PMID 23552443 DOI: 10.1097/WAD.0b013e3182900b2b |
0.709 |
|
| 2013 |
Landau SM, Lu M, Joshi AD, Pontecorvo M, Mintun MA, Trojanowski JQ, Shaw LM, Jagust WJ. Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid. Annals of Neurology. 74: 826-36. PMID 23536396 DOI: 10.1002/Ana.23908 |
0.669 |
|
| 2013 |
Wirth M, Madison CM, Rabinovici GD, Oh H, Landau SM, Jagust WJ. Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 5553-63. PMID 23536070 DOI: 10.1523/Jneurosci.4409-12.2013 |
0.83 |
|
| 2013 |
Wirth M, Oh H, Mormino EC, Markley C, Landau SM, Jagust WJ. The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 687-698.e1. PMID 23474040 DOI: 10.1016/J.Jalz.2012.10.012 |
0.85 |
|
| 2013 |
Foster NL, Jagust WJ, Fox NC. A peek behind the curtain: amyloid imaging, referrals, and specialist memory evaluations. Alzheimer Disease and Associated Disorders. 27: 1-3. PMID 23411640 DOI: 10.1097/Wad.0B013E31828Ab5D8 |
0.327 |
|
| 2013 |
Marchant NL, Reed BR, Sanossian N, Madison CM, Kriger S, Dhada R, Mack WJ, DeCarli C, Weiner MW, Mungas DM, Chui HC, Jagust WJ. The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction. Jama Neurology. 70: 488-95. PMID 23400560 DOI: 10.1001/2013.Jamaneurol.405 |
0.775 |
|
| 2013 |
Kantarci K, Gunter JL, Tosakulwong N, Weigand SD, Senjem MS, Petersen RC, Aisen PS, Jagust WJ, Weiner MW, Jack CR. Focal hemosiderin deposits and β-amyloid load in the ADNI cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: S116-23. PMID 23375568 DOI: 10.1016/J.Jalz.2012.10.011 |
0.475 |
|
| 2013 |
Prestia A, Caroli A, Herholz K, Reiman E, Chen K, Jagust WJ, Frisoni GB. Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 677-86. PMID 23375562 DOI: 10.1016/J.Jalz.2012.09.016 |
0.489 |
|
| 2013 |
Lehmann M, Ghosh PM, Madison C, Laforce R, Corbetta-Rastelli C, Weiner MW, Greicius MD, Seeley WW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain : a Journal of Neurology. 136: 844-58. PMID 23358601 DOI: 10.1093/Brain/Aws327 |
0.428 |
|
| 2013 |
Mander BA, Rao V, Lu B, Saletin JM, Lindquist JR, Ancoli-Israel S, Jagust W, Walker MP. Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in aging. Nature Neuroscience. 16: 357-64. PMID 23354332 DOI: 10.1038/Nn.3324 |
0.805 |
|
| 2013 |
Jagust W. Vulnerable Neural Systems and the Borderland of Brain Aging and Neurodegeneration Neuron. 77: 219-234. PMID 23352159 DOI: 10.1016/j.neuron.2013.01.002 |
0.355 |
|
| 2013 |
Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. The Lancet. Neurology. 12: 207-16. PMID 23332364 DOI: 10.1016/S1474-4422(12)70291-0 |
0.44 |
|
| 2013 |
Landau SM, Breault C, Joshi AD, Pontecorvo M, Mathis CA, Jagust WJ, Mintun MA. Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 70-7. PMID 23166389 DOI: 10.2967/jnumed.112.109009 |
0.678 |
|
| 2013 |
Alkalay A, Rabinovici GD, Zimmerman G, Agarwal N, Kaufer D, Miller BL, Jagust WJ, Soreq H. Plasma acetylcholinesterase activity correlates with intracerebral β-amyloid load. Current Alzheimer Research. 10: 48-56. PMID 23157337 DOI: 10.2174/1567205011310010007 |
0.433 |
|
| 2013 |
Rabinovici G, Possin K, Cohn-Sheehy B, Ghosh P, Madison C, Hess C, Berger M, Kramer JH, Jagust W, Miller B. P4-380: Progressive memory loss with low amyloid burden in former professional American football players Alzheimer's & Dementia. 9: P875-P875. DOI: 10.1016/J.Jalz.2013.08.213 |
0.736 |
|
| 2013 |
Chen K, Stonnington C, Ayutyanont N, Reschke C, Thyyagura P, Protas H, Liu X, Roontiva A, Parks S, Bauer R, Lee W, Koeppe R, Jagust W, Foster N, Weiner M, et al. Baseline FDG-PET and volumetric MRI predicts Alzheimer's disease conversion from mild cognitive impairment: An ADNI study Alzheimers & Dementia. 9: 844. DOI: 10.1016/J.Jalz.2013.08.007 |
0.432 |
|
| 2013 |
Wirth M, Haase CM, Villeneuve S, Madison C, Oh H, Jagust W. P2-131: Relationships between cognitive activity, Alzheimer's disease pathological biomarkers and cognitive functioning in normal older adults Alzheimer's & Dementia. 9: P393-P394. DOI: 10.1016/J.Jalz.2013.05.775 |
0.795 |
|
| 2013 |
Oh H, Madison C, Baker S, Jagust W. Region-specific associations of brain glucose metabolism with age and beta-amyloid deposition in normal aging Alzheimers & Dementia. 9: 393. DOI: 10.1016/J.Jalz.2013.05.773 |
0.686 |
|
| 2013 |
Ossenkoppele R, Madison C, Oh H, Wirth M, Berckel Bv, Jagust W. Is verbal episodic memory in elderly individuals with amyloid deposits preserved through altered neuronal function Alzheimers & Dementia. 9: 392. DOI: 10.1016/J.Jalz.2013.05.771 |
0.696 |
|
| 2013 |
Lehmann M, Ghosh P, Madison C, Karydas A, Coppola G, Miller B, Jagust W, Rabinovici G. P1-272: Reduced amyloid deposition and greater hypometabolism in people with Alzheimer's disease who are APOE-ε4-positive Alzheimer's & Dementia. 9: P253-P253. DOI: 10.1016/J.Jalz.2013.05.497 |
0.422 |
|
| 2013 |
Nosheny R, Insel P, Truran D, Schuff N, Jack C, Aisen P, Petersen R, Jagust W, Shaw L, Trojanowski J, Weiner M. P1-158: The effect of age and amyloid status on hippocampal atrophy rate in normal controls and people with mild cognitive impairment in the ADNI cohort Alzheimer's & Dementia. 9: P207-P207. DOI: 10.1016/J.Jalz.2013.05.381 |
0.416 |
|
| 2013 |
Oh H, Madison C, Baker S, Jagust W. Region-specific associations of brain glucose metabolism with age and beta-amyloid in normal aging Alzheimers & Dementia. 9: 110. DOI: 10.1016/J.Jalz.2013.05.194 |
0.697 |
|
| 2013 |
Caroli A, Prestia A, Wade S, Chen K, Ayutyanont N, Landau S, Madison C, Haense C, Herholz K, Reiman E, Jagust W, Frisoni G. Alzheimer's disease biomarkers as outcome measures for clinical trials Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.1455 |
0.584 |
|
| 2013 |
Protas H, Chen K, Reschke C, Roontiva A, Liu X, Parks S, Lee W, Bauer R, Ayutyanont N, Thiyyagura P, Koeppe R, Jagust W, Foster N, Weiner M, Fleisher A, et al. The pattern of cerebral hypometabolism and its association with clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative Alzheimers & Dementia. 9: 68. DOI: 10.1016/J.Jalz.2013.05.109 |
0.465 |
|
| 2013 |
Risacher S, Petersen R, Aisen P, Jack C, Koeppe R, Jagust W, Farias ST, Mungas D, Trojanowski J, Shaw L, Weiner M, Saykin A. IC-P-105: Self-reported versus informant-based cognitive complaints: Relation of E-Cog scores to imaging biomarkers and clinical status in ADNI-2 Alzheimer's & Dementia. 9: P60-P62. DOI: 10.1016/J.Jalz.2013.05.102 |
0.313 |
|
| 2013 |
Cohn-Sheehy B, Ghosh P, Wirth M, Lehmann M, Madison C, Irwin W, Miller B, Jagust W, Rosen H, Rabinovici G. IC-P-069: Temporoparietal cortical thickness outperforms hippocampal volume as a biomarker for atypical and early-onset Alzheimer's disease Alzheimer's & Dementia. 9: P41-P42. DOI: 10.1016/J.Jalz.2013.05.066 |
0.748 |
|
| 2013 |
Juan PS, Ghosh P, Hagen J, Gesierich B, Henry M, Gorno-Tempini M, Miller B, Jagust W, Rabinovici G. The practical utility of amyloid and FDG-PET in an academic dementia center Alzheimers & Dementia. 9: 22. DOI: 10.1016/J.Jalz.2013.05.024 |
0.405 |
|
| 2013 |
Villeneuve S, Reed B, Madison C, Wirth M, Kriger S, Haase CM, Marchant N, DeCarli CS, Chui H, Weiner M, Jagust W. IC-P-022: The impact of beta-amyloid deposition and vascular risk factors on cortical thickness and cognition Alzheimer's & Dementia. 9: P21-P22. DOI: 10.1016/J.Jalz.2013.05.023 |
0.585 |
|
| 2013 |
Haight T, Landau S, Jagust W. O5-02-05: Relationships among biomarkers in early-stage Alzheimer's disease (AD): Findings in cognitively normal adults from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Alzheimer's & Dementia. 9: P832-P832. DOI: 10.1016/J.Jalz.2013.04.479 |
0.665 |
|
| 2013 |
Oh H, Villeneuve S, Madison C, Vogel J, Jagust W. O4-09-05: Association of gray matter atrophy with age, beta-amyloid, white matter hyperintensity and cognition in normal aging Alzheimer's & Dementia. 9: P701-P702. DOI: 10.1016/J.Jalz.2013.04.387 |
0.766 |
|
| 2013 |
Roontiva A, Chen K, Ayutyanont N, Protas H, Liu X, Thiyyagura P, Lee W, Reschke C, Parks S, Bauer R, Koeppe R, Jagust W, Foster N, Weiner M, Fleisher A, et al. Association between the Alzheimer's disease-related hypometabolic convergence index and clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative Alzheimers & Dementia. 9: 698. DOI: 10.1016/J.Jalz.2013.04.377 |
0.478 |
|
| 2013 |
Jack C, Knopman D, Jagust W, Petersen R, Weiner M, Aisen P, Shaw L, Vemuri P, Wiste H, Weigand S, Lesnick T, Pankratz V, Donohue M, Trojanowski J. O3-03-01: Update on hypothetical model of Alzheimer's disease biomarkers Alzheimer's & Dementia. 9: P521-P522. DOI: 10.1016/J.Jalz.2013.04.248 |
0.34 |
|
| 2013 |
Lehmann M, Seeley W, Ghosh P, Madison C, Miller B, Grinberg L, Trojanowski J, Mendez M, Vinters H, Jagust W, Rabinovici G. O2-10-03: Utility of amyloid PET in the differential diagnosis of dementia: An autopsy-confirmed series Alzheimer's & Dementia. 9: P334-P335. DOI: 10.1016/J.Jalz.2013.04.191 |
0.379 |
|
| 2013 |
Wirth M, Tang G, Villeneuve S, Madison C, Oh H, Jagust W. O1-04-05: High-performing older adults: Cognitive and brain correlates Alzheimer's & Dementia. 9: P134-P134. DOI: 10.1016/J.Jalz.2013.04.071 |
0.583 |
|
| 2013 |
Lehmann M, Ghosh P, Madison C, Karydas A, Coppola G, Miller B, Jagust W, Rabinovici G. IC-O1-04: Reduced amyloid deposition and greater hypometabolism in APOE-ε4-positive Alzheimer's disease patients Alzheimer's & Dementia. 9: P4-P5. DOI: 10.1016/J.Jalz.2013.04.019 |
0.381 |
|
| 2012 |
Jagust WJ, Landau SM. Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 18227-33. PMID 23238736 DOI: 10.1523/JNEUROSCI.3266-12.2012 |
0.64 |
|
| 2012 |
Jagust W. Tracking brain amyloid-β in presymptomatic Alzheimer's disease The Lancet Neurology. 11: 1018-1020. PMID 23137951 DOI: 10.1016/S1474-4422(12)70255-7 |
0.396 |
|
| 2012 |
Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, Weiner MW, Jagust WJ. Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Annals of Neurology. 72: 578-86. PMID 23109153 DOI: 10.1002/Ana.23650 |
0.695 |
|
| 2012 |
Haight TJ, Jagust WJ. Relative contributions of biomarkers in Alzheimer's disease. Annals of Epidemiology. 22: 868-75. PMID 23102709 DOI: 10.1016/J.Annepidem.2012.09.004 |
0.437 |
|
| 2012 |
Toledo JB, Toledo E, Weiner MW, Jack CR, Jagust W, Lee VM, Shaw LM, Trojanowski JQ. Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 483-9. PMID 23102118 DOI: 10.1016/J.Jalz.2011.08.008 |
0.434 |
|
| 2012 |
Cardenas VA, Reed B, Chao LL, Chui H, Sanossian N, DeCarli CC, Mack W, Kramer J, Hodis HN, Yan M, Buonocore MH, Carmichael O, Jagust WJ, Weiner MW. Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults. Stroke; a Journal of Cerebral Circulation. 43: 2865-70. PMID 22984010 DOI: 10.1161/Strokeaha.112.659722 |
0.498 |
|
| 2012 |
Lo RY, Jagust WJ. Vascular burden and Alzheimer disease pathologic progression. Neurology. 79: 1349-55. PMID 22972646 DOI: 10.1212/WNL.0b013e31826c1b9d |
0.71 |
|
| 2012 |
Cohen AD, Rabinovici GD, Mathis CA, Jagust WJ, Klunk WE, Ikonomovic MD. Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta. Advances in Pharmacology (San Diego, Calif.). 64: 27-81. PMID 22840744 DOI: 10.1016/B978-0-12-394816-8.00002-7 |
0.465 |
|
| 2012 |
Dang LC, Donde A, Madison C, O'Neil JP, Jagust WJ. Striatal dopamine influences the default mode network to affect shifting between object features. Journal of Cognitive Neuroscience. 24: 1960-70. PMID 22640392 DOI: 10.1162/jocn_a_00252 |
0.317 |
|
| 2012 |
Stricker NH, Dodge HH, Dowling NM, Han SD, Erosheva EA, Jagust WJ. CSF biomarker associations with change in hippocampal volume and precuneus thickness: implications for the Alzheimer's pathological cascade. Brain Imaging and Behavior. 6: 599-609. PMID 22614327 DOI: 10.1007/S11682-012-9171-6 |
0.44 |
|
| 2012 |
Lo RY, Jagust WJ. Predicting missing biomarker data in a longitudinal study of Alzheimer disease. Neurology. 78: 1376-82. PMID 22491869 DOI: 10.1212/Wnl.0B013E318253D5B3 |
0.706 |
|
| 2012 |
Oh H, Madison C, Haight TJ, Markley C, Jagust WJ. Effects of age and β-amyloid on cognitive changes in normal elderly people. Neurobiology of Aging. 33: 2746-55. PMID 22429886 DOI: 10.1016/J.Neurobiolaging.2012.02.008 |
0.744 |
|
| 2012 |
Caroli A, Prestia A, Chen K, Ayutyanont N, Landau SM, Madison CM, Haense C, Herholz K, Nobili F, Reiman EM, Jagust WJ, Frisoni GB. Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 592-600. PMID 22343502 DOI: 10.2967/Jnumed.111.094946 |
0.686 |
|
| 2012 |
Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, ... ... Jagust W, et al. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proceedings of the National Academy of Sciences of the United States of America. 109: 3985-90. PMID 22343285 DOI: 10.1073/Pnas.1105829109 |
0.676 |
|
| 2012 |
Perrotin A, Mormino EC, Madison CM, Hayenga AO, Jagust WJ. Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals. Archives of Neurology. 69: 223-9. PMID 22332189 DOI: 10.1001/archneurol.2011.666 |
0.678 |
|
| 2012 |
Landau SM, Marks SM, Mormino EC, Rabinovici GD, Oh H, O'Neil JP, Wilson RS, Jagust WJ. Association of lifetime cognitive engagement and low β-amyloid deposition. Archives of Neurology. 69: 623-29. PMID 22271235 DOI: 10.1001/Archneurol.2011.2748 |
0.83 |
|
| 2012 |
Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, Ikonomovic MD, Ishii K, Jack CR, Jagust WJ, Johnson KA, Koeppe RA, Lowe VJ, Masters CL, Montine TJ, et al. Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 39: 209-19. PMID 22218879 DOI: 10.1007/S00259-011-2045-0 |
0.544 |
|
| 2012 |
Reiman EM, Jagust WJ. Brain imaging in the study of Alzheimer's disease. Neuroimage. 61: 505-16. PMID 22173295 DOI: 10.1016/j.neuroimage.2011.11.075 |
0.407 |
|
| 2012 |
Reed BR, Marchant NL, Jagust WJ, DeCarli CC, Mack W, Chui HC. Coronary risk correlates with cerebral amyloid deposition. Neurobiology of Aging. 33: 1979-87. PMID 22078485 DOI: 10.1016/j.neurobiolaging.2011.10.002 |
0.738 |
|
| 2012 |
Marchant NL, Reed BR, DeCarli CS, Madison CM, Weiner MW, Chui HC, Jagust WJ. Cerebrovascular disease, β-amyloid, and cognition in aging. Neurobiology of Aging. 33: 1006.e25-36. PMID 22048124 DOI: 10.1016/J.Neurobiolaging.2011.10.001 |
0.772 |
|
| 2012 |
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, et al. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: S1-68. PMID 22047634 DOI: 10.1016/J.Jalz.2011.09.172 |
0.487 |
|
| 2012 |
Ewers M, Insel P, Jagust WJ, Shaw L, Trojanowski JQ, Aisen P, Petersen RC, Schuff N, Weiner MW. CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cerebral Cortex (New York, N.Y. : 1991). 22: 1993-2004. PMID 22038908 DOI: 10.1093/Cercor/Bhr271 |
0.47 |
|
| 2012 |
Mormino EC, Brandel MG, Madison CM, Marks S, Baker SL, Jagust WJ. Aβ Deposition in aging is associated with increases in brain activation during successful memory encoding. Cerebral Cortex (New York, N.Y. : 1991). 22: 1813-23. PMID 21945849 DOI: 10.1093/Cercor/Bhr255 |
0.602 |
|
| 2012 |
Swaminathan S, Shen L, Risacher SL, Yoder KK, West JD, Kim S, Nho K, Foroud T, Inlow M, Potkin SG, Huentelman MJ, Craig DW, Jagust WJ, Koeppe RA, Mathis CA, et al. Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Brain Imaging and Behavior. 6: 1-15. PMID 21901424 DOI: 10.1007/S11682-011-9136-1 |
0.452 |
|
| 2012 |
Mormino EC, Brandel MG, Madison CM, Rabinovici GD, Marks S, Baker SL, Jagust WJ. Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant. Neuroimage. 59: 1152-60. PMID 21884802 DOI: 10.1016/J.Neuroimage.2011.07.098 |
0.599 |
|
| 2012 |
Klostermann EC, Braskie MN, Landau SM, O'Neil JP, Jagust WJ. Dopamine and frontostriatal networks in cognitive aging. Neurobiology of Aging. 33: 623.e15-24. PMID 21511369 DOI: 10.1016/j.neurobiolaging.2011.03.002 |
0.742 |
|
| 2012 |
Furst AJ, Rabinovici GD, Rostomian AH, Steed T, Alkalay A, Racine C, Miller BL, Jagust WJ. Cognition, glucose metabolism and amyloid burden in Alzheimer's disease. Neurobiology of Aging. 33: 215-25. PMID 20417582 DOI: 10.1016/J.Neurobiolaging.2010.03.011 |
0.462 |
|
| 2012 |
Rabinovici G, Jagust W, Ghosh P, Madison C, Karydas A, Boxer A, Trojanowski J, Miller B, Shaw L, Rosen H. Comparison of Amyloid PET and CSF Biomarkers in the Evaluation of Dementia (PD1.004) Neurology. 78: PD1.004-PD1.004. DOI: 10.1212/Wnl.78.1_Meetingabstracts.Pd1.004 |
0.354 |
|
| 2012 |
Prestia A, Caroli A, Herholz K, Reiman E, Jagust W, Chen K, Frisoni G. Accuracy of different biomarkers to predict progression from mild cognitive impairment to probable Alzheimer's dementia in two independent clinical series Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.426 |
0.431 |
|
| 2012 |
Haight T, Jagust W. P1-023: Longitudinal relationships among biomarkers in Alzheimer's disease: Findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Alzheimer's & Dementia. 8: P115-P115. DOI: 10.1016/J.Jalz.2012.05.298 |
0.406 |
|
| 2012 |
Foster N, King R, Wang A, Landau S, Jagust W, Chen K, Reiman E. Discrepant diagnostic classification with AV45-PET and FDG-PET of clinically diagnosed Alzheimer's patients in the Alzheimer's Disease Neuroimaging Initiative Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.282 |
0.638 |
|
| 2012 |
Wirth M, Oh H, Mormino EC, Landau S, Jagust W. O1-10-02: Beta-amyloid deposition in normal elderly is related to longitudinal but not cross-sectional cognitive decline Alzheimer's & Dementia. 8: P102-P102. DOI: 10.1016/J.Jalz.2012.05.258 |
0.802 |
|
| 2012 |
Tosun D, Laforce R, Ghosh P, Madison C, Weiner M, Miller B, Jagust W, Rabinovici G. O4-09-05: Multivariate data analysis of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology Alzheimer's & Dementia. 8: P632-P633. DOI: 10.1016/J.Jalz.2012.05.1687 |
0.37 |
|
| 2012 |
Lehmann M, Ghosh P, Madison C, Corbetta C, Long A, Miller B, Jagust W, Rabinovici G. O4-09-04: Diverging PIB and FDG covariance patterns across clinical variants of Alzheimer's disease Alzheimer's & Dementia. 8: P632-P632. DOI: 10.1016/J.Jalz.2012.05.1686 |
0.37 |
|
| 2012 |
Jagust W, Landau S. F4-01-04: Amyloid imaging in the multimodal evaluation of MCI Alzheimer's & Dementia. 8: P607-P608. DOI: 10.1016/j.jalz.2012.05.1628 |
0.594 |
|
| 2012 |
Risacher S, Kim S, Shen L, Ngo K, Foroud T, Petersen R, Aisen P, Jack C, Koeppe R, Jagust W, Weiner M, Saykin A. IC-P-098: The role of APOE-ɛ4 genotype in early mild cognitive impairment (EMCI): Preliminary results from ADNI-2 Alzheimer's & Dementia. 8: P56-P57. DOI: 10.1016/J.Jalz.2012.05.131 |
0.373 |
|
| 2012 |
Jagust W. Aging, amyloid and neural activity Alzheimers & Dementia. 8: 427. DOI: 10.1016/J.Jalz.2012.05.1138 |
0.316 |
|
| 2012 |
Vossel KA, Beagle A, Hegde M, Mantle M, Kirsch H, Garcia P, Honma S, Findlay A, Rabinovici G, Jagust W, Nagarajan S, Miller B, Roberson E, Mucke L. P2-377: Subclinical epileptiform activity in Alzheimer's disease Alzheimer's & Dementia. 8: P395-P396. DOI: 10.1016/J.Jalz.2012.05.1087 |
0.367 |
|
| 2012 |
Protas H, Chen K, Reschke C, Roontiva A, Lee W, Nishimura M, Ayutyanont N, Liu X, Thiyyagura P, Parks S, Koeppe R, Jagust W, Foster N, Weiner M, Fleisher A, et al. Capitalizing on complementary FDG-PET and florbetapir-PET data sets to distinguish between early and late mild cognitive impairment using multimodal partial least squares Alzheimers & Dementia. 8: 20. DOI: 10.1016/J.Jalz.2012.05.056 |
0.376 |
|
| 2011 |
Rabinovici GD, Rosen HJ, Alkalay A, Kornak J, Furst AJ, Agarwal N, Mormino EC, O'Neil JP, Janabi M, Karydas A, Growdon ME, Jang JY, Huang EJ, Dearmond SJ, Trojanowski JQ, ... ... Jagust WJ, et al. Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology. 77: 2034-42. PMID 22131541 DOI: 10.1212/Wnl.0B013E31823B9C5E |
0.624 |
|
| 2011 |
Jagust WJ, Mormino EC. Lifespan brain activity, β-amyloid, and Alzheimer's disease. Trends in Cognitive Sciences. 15: 520-6. PMID 21983147 DOI: 10.1016/j.tics.2011.09.004 |
0.691 |
|
| 2011 |
Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Thompson PM, Reiman EM, Jack CR, Fox NC, Jagust WJ, Harvey DJ, Beckett LA, Gamst A, Aisen PS, et al. Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 514-20. PMID 21889115 DOI: 10.1016/J.Jalz.2010.12.010 |
0.529 |
|
| 2011 |
Toledo JB, Vanderstichele H, Figurski M, Aisen PS, Petersen RC, Weiner MW, Jack CR, Jagust W, Decarli C, Toga AW, Toledo E, Xie SX, Lee VM, Trojanowski JQ, Shaw LM, et al. Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI. Acta Neuropathologica. 122: 401-13. PMID 21805181 DOI: 10.1007/S00401-011-0861-8 |
0.521 |
|
| 2011 |
Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust WJ. Longitudinal change of biomarkers in cognitive decline. Archives of Neurology. 68: 1257-66. PMID 21670386 DOI: 10.1001/Archneurol.2011.123 |
0.706 |
|
| 2011 |
Frisoni GB, Jagust WJ. Subcortical vascular dementia exists! Neurology. 77: 12-3. PMID 21593436 DOI: 10.1212/WNL.0b013e318221ad59 |
0.438 |
|
| 2011 |
Rosenbloom MH, Alkalay A, Agarwal N, Baker SL, O'Neil JP, Janabi M, Yen IV, Growdon M, Jang J, Madison C, Mormino EC, Rosen HJ, Gorno-Tempini ML, Weiner MW, Miller BL, ... Jagust WJ, et al. Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology. 76: 1789-96. PMID 21525424 DOI: 10.1212/Wnl.0B013E31821Cccad |
0.663 |
|
| 2011 |
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 270-9. PMID 21514249 DOI: 10.1016/j.jalz.2011.03.008 |
0.35 |
|
| 2011 |
Tosun D, Schuff N, Mathis CA, Jagust W, Weiner MW. Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain : a Journal of Neurology. 134: 1077-88. PMID 21429865 DOI: 10.1093/Brain/Awr044 |
0.455 |
|
| 2011 |
Mormino EC, Smiljic A, Hayenga AO, Onami SH, Greicius MD, Rabinovici GD, Janabi M, Baker SL, Yen IV, Madison CM, Miller BL, Jagust WJ. Relationships between β-amyloid and functional connectivity in different components of the default mode network in aging. Cerebral Cortex (New York, N.Y. : 1991). 21: 2399-407. PMID 21383234 DOI: 10.1093/Cercor/Bhr025 |
0.658 |
|
| 2011 |
Chen K, Ayutyanont N, Langbaum JB, Fleisher AS, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Shaw L, Trojanowski JQ, Jack CR, Landau SM, Foster NL, ... ... Jagust WJ, et al. Characterizing Alzheimer's disease using a hypometabolic convergence index. Neuroimage. 56: 52-60. PMID 21276856 DOI: 10.1016/J.Neuroimage.2011.01.049 |
0.708 |
|
| 2011 |
Womack KB, Diaz-Arrastia R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Clark CM, DeCarli CS, Jagust WJ, Leverenz JB, Peskind ER, Turner RS, Zamrini EY, Heidebrink JL, Burke JR, et al. Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. Archives of Neurology. 68: 329-37. PMID 21059987 DOI: 10.1001/Archneurol.2010.295 |
0.556 |
|
| 2011 |
Oh H, Mormino EC, Madison C, Hayenga A, Smiljic A, Jagust WJ. β-Amyloid affects frontal and posterior brain networks in normal aging. Neuroimage. 54: 1887-95. PMID 20965254 DOI: 10.1016/J.Neuroimage.2010.10.027 |
0.811 |
|
| 2011 |
Braskie MN, Landau SM, Wilcox CE, Taylor SD, O'Neil JP, Baker SL, Madison CM, Jagust WJ. Correlations of striatal dopamine synthesis with default network deactivations during working memory in younger adults. Human Brain Mapping. 32: 947-61. PMID 20578173 DOI: 10.1002/Hbm.21081 |
0.742 |
|
| 2011 |
Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiology of Aging. 32: 1207-18. PMID 19660834 DOI: 10.1016/J.Neurobiolaging.2009.07.002 |
0.684 |
|
| 2011 |
Landau SM, Jagust WJ. Reply from the authors Neurology. 76: 106. DOI: 10.1212/WNL.0b013e3181fe6f47 |
0.644 |
|
| 2011 |
Saykin A, Swaminathan S, Risacher S, Yoder K, West J, Shen L, Kim S, Inlow M, Foroud T, Jagust W, Koeppe R, Mathis C. P4-363: APOE e4 status modulates the association of plasma and cortical Aβ: Relation of plasma Aβ and [11C]PiB PET in the ADNI cohort Alzheimer's & Dementia. 7: e39-e39. DOI: 10.1016/J.Jalz.2011.09.177 |
0.344 |
|
| 2011 |
Reed B, Marchant N, Jagust W, Decarli C, Chui H. Coronary risk correlates with cerebral amyloid deposition in non demented elders Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.874 |
0.464 |
|
| 2011 |
Ayutyanont N, Chen K, Roontiva A, Fleisher A, Langbaum J, Reschke C, Lee W, Liu X, Bandy D, Alexander G, Foster N, Harvey D, Weiner M, Koeppe R, Jagust W, et al. Use of an FDG-PET derived hypometabolic convergence index enrichment strategy to reduce sample sizes in Alzheimer's disease clinical trials: findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.150 |
0.407 |
|
| 2011 |
Marchant N, Madison C, Martinez O, Carmichael O, DeCarli C, Reed B, Jagust W. Effects of MRI markers of cerebrovascular disease on amyloid burden and cognition in aging Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1224 |
0.572 |
|
| 2011 |
Landau S, Petersen R, Aisen P, Jagust W. IC-P-049: Change in amyloid deposition is related to concurrent cognitive change in MCI Alzheimer's & Dementia. 7: S28-S28. DOI: 10.1016/J.Jalz.2011.05.118 |
0.612 |
|
| 2010 |
Gabel MJ, Foster NL, Heidebrink JL, Higdon R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Burke JR, Clark CM, Dekosky ST, Farlow MR, Jagust WJ, Kawas CH, Koeppe RA, et al. Validation of consensus panel diagnosis in dementia. Archives of Neurology. 67: 1506-12. PMID 21149812 DOI: 10.1001/Archneurol.2010.301 |
0.325 |
|
| 2010 |
Jagust WJ. Amyloid imaging: coming to a PET scanner near you. Annals of Neurology. 68: 277-8. PMID 20818786 DOI: 10.1002/ana.22144 |
0.358 |
|
| 2010 |
Wilcox CE, Braskie MN, Kluth JT, Jagust WJ. Overeating Behavior and Striatal Dopamine with 6-[F]-Fluoro-L-m-Tyrosine PET. Journal of Obesity. 2010. PMID 20798859 DOI: 10.1155/2010/909348 |
0.633 |
|
| 2010 |
Wu X, Chen K, Yao L, Ayutyanont N, Langbaum JB, Fleisher A, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Foster NL, Thompson PM, Harvey DJ, Weiner MW, ... ... Jagust WJ, et al. Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment. Journal of Neuroscience Methods. 192: 277-85. PMID 20678521 DOI: 10.1016/J.Jneumeth.2010.07.030 |
0.53 |
|
| 2010 |
Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Petersen RC, Shaw LM, Trojanowski JQ, Jack CR, Weiner MW, Jagust WJ. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology. 75: 230-8. PMID 20592257 DOI: 10.1212/Wnl.0B013E3181E8E8B8 |
0.701 |
|
| 2010 |
Apostolova LG, Hwang KS, Andrawis JP, Green AE, Babakchanian S, Morra JH, Cummings JL, Toga AW, Trojanowski JQ, Shaw LM, Jack CR, Petersen RC, Aisen PS, Jagust WJ, Koeppe RA, et al. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiology of Aging. 31: 1284-303. PMID 20538372 DOI: 10.1016/J.Neurobiolaging.2010.05.003 |
0.475 |
|
| 2010 |
Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR, Jagust W, Toga AW, Saykin AJ, Morris JC, et al. Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 239-46. PMID 20451872 DOI: 10.1016/J.Jalz.2010.03.006 |
0.442 |
|
| 2010 |
Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR, ... Jagust W, et al. Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 230-8. PMID 20451871 DOI: 10.1016/J.Jalz.2010.03.008 |
0.466 |
|
| 2010 |
Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 221-9. PMID 20451870 DOI: 10.1016/J.Jalz.2010.03.003 |
0.656 |
|
| 2010 |
Weiner MW, Aisen PS, Jack CR, Jagust WJ, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, et al. The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 202-11.e7. PMID 20451868 DOI: 10.1016/J.Jalz.2010.03.007 |
0.512 |
|
| 2010 |
Chen K, Langbaum JB, Fleisher AS, Ayutyanont N, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Foster NL, Harvey DJ, de Leon MJ, Koeppe RA, Jagust WJ, et al. Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative. Neuroimage. 51: 654-64. PMID 20202480 DOI: 10.1016/J.Neuroimage.2010.02.064 |
0.559 |
|
| 2010 |
Lavretsky H, Zheng L, Weiner MW, Mungas D, Reed B, Kramer JH, Jagust W, Chui H, Mack WJ. Association of depressed mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic study. The American Journal of Psychiatry. 167: 589-97. PMID 20160005 DOI: 10.1176/Appi.Ajp.2009.09020280 |
0.358 |
|
| 2010 |
Kuczynski B, Targan E, Madison C, Weiner M, Zhang Y, Reed B, Chui HC, Jagust W. White matter integrity and cortical metabolic associations in aging and dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 54-62. PMID 20129319 DOI: 10.1016/J.Jalz.2009.04.1228 |
0.36 |
|
| 2010 |
Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. The Lancet. Neurology. 9: 119-28. PMID 20083042 DOI: 10.1016/S1474-4422(09)70299-6 |
0.473 |
|
| 2010 |
Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neil JP, Janabi M, Baker SL, Agarwal N, Bonasera SJ, Mormino EC, Weiner MW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain : a Journal of Neurology. 133: 512-28. PMID 20080878 DOI: 10.1093/Brain/Awp326 |
0.659 |
|
| 2010 |
Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, Jack CR, Jagust WJ, Shaw LM, Toga AW, Trojanowski JQ, Weiner MW. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 74: 201-9. PMID 20042704 DOI: 10.1212/Wnl.0B013E3181Cb3E25 |
0.438 |
|
| 2010 |
Tosun D, Schuff N, Jagust W, Weiner MW. O4-03-02: Relationship Between Regional Brain Amyloid-β Deposition and Brain Atrophy Rates in Mild Cognitive Impairment Alzheimer's & Dementia. 6: e15-e15. DOI: 10.1016/J.Jalz.2010.08.047 |
0.383 |
|
| 2010 |
Foster NL, Wang AY, Fletcher PT, Joshi S, Minoshima S, Jagust WJ, Chen K, Reiman EM, Weiner MW. Topographic extent of cerebral hypometabolism predicts time of conversion from aMCI to Alzheimer's disease: Data from the Alzheimer's Disease Neuroimaging Initiative Alzheimer's & Dementia. 6: S298. DOI: 10.1016/J.Jalz.2010.05.976 |
0.394 |
|
| 2010 |
Chen K, Ayutyanont N, Langbaum J, Fleisher A, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Yu M, Foster NL, Weiner MW, Thompson PM, Koeppe RA, Jagust WJ, et al. Use of an Alzheimer's Disease-Related Hypometabolic Convergence Index to Predict Progression from Mild Cognitive Impairment to Alzheimer's Dementia Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.971 |
0.544 |
|
| 2010 |
Landau SM, Harvey D, Reiman EM, Foster NL, Aisen PS, Trojanowski JQ, Shaw L, Jack CR, Petersen RC, Weiner MW, Jagust WJ. O3-03-08: Biomarker predictors of cognitive decline in healthy older participants in the Alzheimer's Disease Neuroimaging Initiative Alzheimer's & Dementia. 6: S131-S131. DOI: 10.1016/J.Jalz.2010.05.411 |
0.65 |
|
| 2010 |
Jack CR, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Knopman DS, Bernstein MA, Gunter JL, Aisen PS, Weiner MW, Petersen RC, Jagust WJ, Shaw LM, Trojanowski JQ. Brain Aβ amyloid measures and MRI are complimentary predictors of progression from MCI to Alzheimer's disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.307 |
0.451 |
|
| 2010 |
Rabinovici GD, Alkalay A, Marchant NL, DeCarli C, Chui HC, Reed BR, Jagust WJ. IC-03-03: Amyloid and cerebrovascular disease both contribute to cognitive impairment in individuals with high vascular risk Alzheimer's & Dementia. 6: S59-S59. DOI: 10.1016/J.Jalz.2010.05.165 |
0.53 |
|
| 2010 |
Rabinovici GD, Alkalay A, Rosen HJ, Furst AJ, Agarwal N, O'Neil JP, Jang JY, Growdon ME, Yen IV, Madison C, Baker SL, Gorno-Tempini ML, Seeley WW, Miller BL, Jagust WJ. IC-P-132: Comparison of [11C]PIB and [18F]FDG PET in Discriminating Alzheimer's Disease and Frontotemporal Lobar Degeneration Alzheimer's & Dementia. 6: S52-S53. DOI: 10.1016/J.Jalz.2010.05.147 |
0.382 |
|
| 2010 |
Fletcher PT, Kumar A, Wang AY, Jagust WJ, Chen K, Reiman EM, Weiner MW, Foster NL. Regression-to-pons normalization of FDG-PET improves discrimination of Alzheimer's disease from healthy aging Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.031 |
0.422 |
|
| 2009 |
Jagust WJ. Genes and cognitive aging. Frontiers in Neuroscience. 3: 161-163. PMID 20228865 DOI: 10.3389/Neuro.01.020.2009 |
0.363 |
|
| 2009 |
Van Boven RW, Harrington GS, Hackney DB, Ebel A, Gauger G, Bremner JD, D'Esposito M, Detre JA, Haacke EM, Jack CR, Jagust WJ, Le Bihan D, Mathis CA, Mueller S, Mukherjee P, et al. Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder. Journal of Rehabilitation Research and Development. 46: 717-57. PMID 20104401 DOI: 10.1682/Jrrd.2008.12.0161 |
0.459 |
|
| 2009 |
Schuff N, Matsumoto S, Kmiecik J, Studholme C, Du A, Ezekiel F, Miller BL, Kramer JH, Jagust WJ, Chui HC, Weiner MW. Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 454-62. PMID 19896584 DOI: 10.1016/J.Jalz.2009.04.1233 |
0.406 |
|
| 2009 |
Rabinovici GD, Jagust WJ. Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo. Behavioural Neurology. 21: 117-28. PMID 19847050 DOI: 10.3233/BEN-2009-0232 |
0.419 |
|
| 2009 |
Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, Reiman EM, Foster NL, Petersen RC, Weiner MW, Price JC, Mathis CA. Relationships between biomarkers in aging and dementia. Neurology. 73: 1193-9. PMID 19822868 DOI: 10.1212/Wnl.0B013E3181Bc010C |
0.686 |
|
| 2009 |
Barnes DE, Yaffe K, Belfor N, Jagust WJ, DeCarli C, Reed BR, Kramer JH. Computer-based cognitive training for mild cognitive impairment: results from a pilot randomized, controlled trial. Alzheimer Disease and Associated Disorders. 23: 205-10. PMID 19812460 DOI: 10.1097/Wad.0B013E31819C6137 |
0.482 |
|
| 2009 |
Haense C, Herholz K, Jagust WJ, Heiss WD. Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI). Dementia and Geriatric Cognitive Disorders. 28: 259-66. PMID 19786778 DOI: 10.1159/000241879 |
0.436 |
|
| 2009 |
Jagust W. Amyloid + activation = Alzheimer's? Neuron. 63: 141-143. PMID 19640471 DOI: 10.1016/J.Neuron.2009.07.008 |
0.494 |
|
| 2009 |
Jagust W. Mapping Brain β-Amyloid Current Opinion in Neurology. 22: 356-361. PMID 19478666 DOI: 10.1097/Wco.0B013E32832D93C7 |
0.429 |
|
| 2009 |
Langbaum JB, Chen K, Lee W, Reschke C, Bandy D, Fleisher AS, Alexander GE, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM. Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage. 45: 1107-16. PMID 19349228 DOI: 10.1016/J.Neuroimage.2008.12.072 |
0.488 |
|
| 2009 |
Kuczynski B, Jagust W, Chui HC, Reed BR. An inverse association of cardiovascular risk and frontal lobe glucose metabolism Neurology. 72: 738-743. PMID 19237703 DOI: 10.1212/01.Wnl.0000343005.35498.E5 |
0.4 |
|
| 2009 |
Cools R, Frank MJ, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M. Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 1538-43. PMID 19193900 DOI: 10.1523/JNEUROSCI.4467-08.2009 |
0.691 |
|
| 2009 |
Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain : a Journal of Neurology. 132: 1310-23. PMID 19042931 DOI: 10.1093/Brain/Awn320 |
0.666 |
|
| 2009 |
Landau SM, Lal R, O'Neil JP, Baker S, Jagust WJ. Striatal dopamine and working memory. Cerebral Cortex (New York, N.Y. : 1991). 19: 445-54. PMID 18550595 DOI: 10.1093/Cercor/Bhn095 |
0.581 |
|
| 2009 |
Furst AJ, Mormino EC, Steed T, Rostomian AH, Mathis CA, Jack CR, Jagust WJ. IC-P-076: Hippocampal volume loss is associated with increased A-beta levels in the precuneus in mild cognitive impairment Alzheimer's & Dementia. 5: P35-P36. DOI: 10.1016/j.jalz.2009.05.630 |
0.59 |
|
| 2009 |
Landau SM, Harvey D, Madison C, Foster NL, Reiman EM, Shaw LM, Trojanowski JQ, Petersen RC, Weiner MW, Jagust WJ. O3-01-01: Comparing predictors of conversion: Data from the Alzheimer's Disease Neuroimaging Initiative Alzheimer's & Dementia. 5: P125-P125. DOI: 10.1016/J.Jalz.2009.05.421 |
0.6 |
|
| 2009 |
Mormino EC, Smiljic A, Baker SL, Hayenga AO, Madison CM, Jagust WJ. O2-01-01: Beta-amyloid deposition is related to default mode network connectivity in normal controls Alzheimer's & Dementia. 5: P100-P100. DOI: 10.1016/J.Jalz.2009.05.316 |
0.552 |
|
| 2009 |
Jagust W. Will Neuroimaging help us understand Alzheimer's disease? Alzheimers & Dementia. 5: 1. DOI: 10.1016/J.Jalz.2009.05.002 |
0.386 |
|
| 2009 |
Perrotin A, Mormino BC, Madison CM, Hayenga AO, Jagust WJ. Metacognitive monitoring abilities and amyloid deposition imaging in normal elderly individuals Alzheimers & Dementia. 5. DOI: 10.1016/J.Jalz.2009.04.147 |
0.339 |
|
| 2008 |
Braskie MN, Wilcox CE, Landau SM, O'Neil JP, Baker SL, Madison CM, Kluth JT, Jagust WJ. Relationship of striatal dopamine synthesis capacity to age and cognition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 14320-8. PMID 19109513 DOI: 10.1523/Jneurosci.3729-08.2008 |
0.744 |
|
| 2008 |
DeCarli C, Reed BR, Jagust W, Martinez O, Ortega M, Mungas D. Brain behavior relationships among African Americans, whites, and Hispanics. Alzheimer Disease and Associated Disorders. 22: 382-91. PMID 19068502 DOI: 10.1097/WAD.0b013e318185e7fe |
0.517 |
|
| 2008 |
Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, O'Neil JP, Lal RA, Dronkers NF, Miller BL, Gorno-Tempini ML. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Annals of Neurology. 64: 388-401. PMID 18991338 DOI: 10.1002/Ana.21451 |
0.652 |
|
| 2008 |
Farias ST, Mungas D, Reed BR, Cahn-Weiner D, Jagust W, Baynes K, Decarli C. The measurement of everyday cognition (ECog): scale development and psychometric properties. Neuropsychology. 22: 531-44. PMID 18590364 DOI: 10.1037/0894-4105.22.4.531 |
0.524 |
|
| 2008 |
Kuczynski B, Reed B, Mungas D, Weiner M, Chui HC, Jagust W. Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease. Archives of Neurology. 65: 650-5. PMID 18474742 DOI: 10.1001/Archneur.65.5.650 |
0.481 |
|
| 2008 |
Garrod MG, Green R, Allen LH, Mungas DM, Jagust WJ, Haan MN, Miller JW. Fraction of total plasma vitamin B12 bound to transcobalamin correlates with cognitive function in elderly Latinos with depressive symptoms. Clinical Chemistry. 54: 1210-7. PMID 18451312 DOI: 10.1373/Clinchem.2007.102632 |
0.321 |
|
| 2008 |
Lavretsky H, Zheng L, Weiner MW, Mungas D, Reed B, Kramer JH, Jagust W, Chui H, Mack WJ. The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia. International Journal of Geriatric Psychiatry. 23: 1040-50. PMID 18412291 DOI: 10.1002/Gps.2030 |
0.385 |
|
| 2008 |
Jagust W. Is amnestic mild cognitive impairment always AD Neurology. 70: 502-503. PMID 18268243 DOI: 10.1212/01.Wnl.0000299190.17488.B3 |
0.46 |
|
| 2008 |
Cools R, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M. Working memory capacity predicts dopamine synthesis capacity in the human striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 1208-12. PMID 18234898 DOI: 10.1523/JNEUROSCI.4475-07.2008 |
0.712 |
|
| 2008 |
Jagust WJ, Zheng L, Harvey DJ, Mack WJ, Vinters HV, Weiner MW, Ellis WG, Zarow C, Mungas D, Reed BR, Kramer JH, Schuff N, DeCarli C, Chui HC. Neuropathological basis of magnetic resonance images in aging and dementia. Annals of Neurology. 63: 72-80. PMID 18157909 DOI: 10.1002/Ana.21296 |
0.6 |
|
| 2008 |
Haan MN, Aiello AE, West NA, Jagust WJ. C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype. Neurobiology of Aging. 29: 1774-82. PMID 17540481 DOI: 10.1016/J.Neurobiolaging.2007.04.020 |
0.439 |
|
| 2008 |
Chen K, Lee W, Liu X, Alexander G, Bandy D, Reschke C, Foster N, Weiner M, Koeppe R, Jagust W, Reiman E. P1-338: The consistency of hypometabolic brain voxels in probable Alzheimer's disease and amnestic mild cognitive impairment patients from the Alzheimer's disease neuroimaging initiative Alzheimer's & Dementia. 4: T318-T318. DOI: 10.1016/J.Jalz.2008.05.919 |
0.458 |
|
| 2008 |
Ayutyanont N, Chen K, Liu X, Reschke C, Lee W, Bandy D, Alexander GE, Jagust WJ, Koeppe RA, Foster NL, Reiman EM. P1-312: Differentiating amnestic mild cognitive impairment converting to probable Alzheimer's disease from stable amnestic mild cognitive impairment using FDG-PET and an Alzheimer's disease-related hypometabolism overlap index Alzheimer's & Dementia. 4: T312-T312. DOI: 10.1016/J.Jalz.2008.05.903 |
0.473 |
|
| 2008 |
Rabinovici GD, Furst AJ, Mormino EC, O'Neil JP, Steed T, Turken M, Kluth J, Madison C, Miller BL, Jagust WJ. P1-280: Amyloid and glucose metabolism in early versus late-onset Alzheimer's disease: A comparative [11C]PIBand [18F]FDG PET study Alzheimer's & Dementia. 4: T299-T299. DOI: 10.1016/J.Jalz.2008.05.870 |
0.629 |
|
| 2008 |
Mormino EC, Hayenga AO, Madison CM, Kluth JT, Furst AJ, Rabinovici GD, Jagust WJ. P1-267: Metabolic evidence of compensation for amyloid pathology in nondemented elderly individuals Alzheimer's & Dementia. 4: T295-T295. DOI: 10.1016/j.jalz.2008.05.857 |
0.597 |
|
| 2008 |
Landau SM, Madison C, Wu D, Cheung C, Foster N, Reiman E, Koeppe R, Weiner M, Jagust WJ. P1-258: Pinpointing change in Alzheimer's disease: Longitudinal FDG-PET analyses from the Alzheimer's disease neuroimaging initiative Alzheimer's & Dementia. 4: T291-T292. DOI: 10.1016/J.Jalz.2008.05.848 |
0.648 |
|
| 2008 |
Madison C, Landau S, Cheung C, Lal R, Foster N, Reiman E, Koeppe R, Weiner M, Jagust W. IC-P2-114: Meta-analysis ROIs and minimal deformation templates improve PET-FDG as a candidate biomarker in Alzheimer's disease Alzheimer's & Dementia. 4: T53-T53. DOI: 10.1016/J.Jalz.2008.05.2569 |
0.653 |
|
| 2008 |
Rabinovici GD, Furst AJ, Mormino EC, O'Neil JP, Steed T, Turken M, Kluth J, Madison C, Miller BL, Jagust WJ. IC-01-06: Amyloid and glucose metabolism in early versus late-onset AD: A comparative [11C]PIB and [18F]FDG PET study Alzheimer's & Dementia. 4: T4-T4. DOI: 10.1016/J.Jalz.2008.05.2492 |
0.618 |
|
| 2008 |
Reiman EM, Chen K, Ayutyanont N, Lee W, Bandy D, Reschke C, Alexander GE, Weiner MW, Koeppe RA, Foster NL, Jagust WJ. O1-02-06: Twelve-month cerebral metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment: Preliminary findings from the Alzheimer's disease neuroimaging initiative (ADNI) Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.225 |
0.345 |
|
| 2008 |
Jagust W. S1-01-05: The current role of FDG-PET studies in dementia Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.187 |
0.365 |
|
| 2008 |
Reed B, Mungas D, Kramer JH, Ellis W, Vinters HV, Zarow C, DeCarli C, Jagust WJ, Chui HC. P3-173: Verbal list learning in cases with Alzheimer's disease, vascular, and mixed neuropathology Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1739 |
0.49 |
|
| 2008 |
Chen K, Reschke C, Lee W, Bandy D, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM. IC-P2-086: The pattern of cerebral hypometablism in amnestic mild cognitive impairment and its relationship to subsequent conversion to probable Alzheimer's disease: Preliminary findings from the Alzheimer's disease neuroimaging initiative Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.079 |
0.444 |
|
| 2008 |
Ayutyanont N, Chen K, Liu X, Reschke C, Lee W, Bandy D, Alexander GE, Jagust WJ, Koeppe RA, Foster NL, Reiman EM. IC-P2-074: Differentiating amnestic MCI converting to probable AD from stable amnestic MCI using FDG-PET and an AD-related hypometabolism overlap index Alzheimer's & Dementia. 4: T38-T38. DOI: 10.1016/J.Jalz.2008.05.067 |
0.421 |
|
| 2008 |
Lee W, Langbaum JBS, Chen K, Recshke C, Bandy D, Alexander GE, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM. IC-P1-036: Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's disease neuroimaging initiative Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.047 |
0.384 |
|
| 2008 |
Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Toga AW, Beckett L. Alzheimer's Disease Neuroimaging Initiative Neuroimage. 45: 183-189. DOI: 10.1007/978-0-387-72076-0_18 |
0.393 |
|
| 2007 |
Eberling JL, Bankiewicz KS, O'Neil JP, Jagust WJ. PET 6-[F]fluoro-L-m-tyrosine Studies of Dopaminergic Function in Human and Nonhuman Primates. Frontiers in Human Neuroscience. 1: 9. PMID 18958223 DOI: 10.3389/neuro.09.009.2007 |
0.34 |
|
| 2007 |
Jagust W, Reed BR, Mungas DM, Ellis W, DeCarli C. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia Neurology. 69: 871-877. PMID 17724289 DOI: 10.1212/01.Wnl.0000269790.05105.16 |
0.579 |
|
| 2007 |
Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR, DeCarli CS, Turner RS, Koeppe RA, Higdon R, Minoshima S. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain : a Journal of Neurology. 130: 2616-35. PMID 17704526 DOI: 10.1093/Brain/Awm177 |
0.551 |
|
| 2007 |
Boxer AL, Rabinovici GD, Kepe V, Goldman J, Furst AJ, Huang SC, Baker SL, O'neil JP, Chui H, Geschwind MD, Small GW, Barrio JR, Jagust W, Miller BL. Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease. Neurology. 69: 283-90. PMID 17636066 DOI: 10.1212/01.Wnl.0000265815.38958.B6 |
0.453 |
|
| 2007 |
Jagust W. What can imaging reveal about obesity and the brain Current Alzheimer Research. 4: 135-139. PMID 17430236 DOI: 10.2174/156720507780362146 |
0.319 |
|
| 2007 |
Rabinovici GD, Furst AJ, O'Neil JP, Racine CA, Mormino EC, Baker SL, Chetty S, Patel P, Pagliaro TA, Klunk WE, Mathis CA, Rosen HJ, Miller BL, Jagust WJ. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology. 68: 1205-12. PMID 17420404 DOI: 10.1212/01.Wnl.0000259035.98480.Ed |
0.662 |
|
| Show low-probability matches. |
